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1. This study is based on material from two mouse mutants - the
"wobbler" mutant, (which manifests a homozygous recessive lower motor
neurone disorder which resembles human spinal muscular atrophy), and
the ReJ/129 dystrophic mutant, (which manifests a homozygous recessive
neuromuscular disease with certain similarities to human Duchenne type
muscular dystrophy)# Control material has been obtained from mice of
the C57/BL colony as these animals are free from neuromuscular disease#
2. The work can essentially be divided into three main sections -
clinical and genetic studies carried out largely on mice of the wobbler
colony using the dystrophic colony as the control; biochemical studies
carried out on mice from all three colonies; and histological and
histochemical studies of which some were carried out on mice of all
three colonies, but of which studies of muscle and spinal cord histology
were primarily based on material from mice of the wobbler colony.
3# The clinical and genetic studies were carried out in order to
verify the genetics of the "wobbler" mutant, also to consider the gene¬
tics and a method for possible early diagnosis of the late onset hind-
limb paralysis disorder which occurred in several mice of the wobbler
colony. These mice have been referred to as Wr/HLP mice throughout
the study# Although no method for early diagnosis was found, the gene¬
tic studies showed that the Wr/HLP mouse could be a manifesting hetiro-
zygote for the mutant "wr" gene.
4# The biochemical studies were carried out on specimens of spinal
cord. The free amino-acid content of the cervical and lumbar enlarge¬
ments was assessed by means of column chromatography. The results indi¬
cated altered amino-acid profiles in mice from both mutant colonies.
The most consistent finding was an increased horaocarnosine level in
wobbler mice cervical and lumbar enlargements. The possible role of
neurotransmitter amino-acids in the disease processes in both wobbler
and dystrophic mice has been discussed.
5. The histological and histochemical studies can further be divided
into three sections: studies of terminal innervation and end-plate
morphology, histological and histochemical investigations of muscle,
and studies of spinal cord histology.
6. The functional terminal innervation ratio, the end-plate size and
end-plate morphology was studied in the gastrocnemius muscle. The
bOBtbined acetylcholinesterase-silver technique was used for staining
the muscle. Increased FTIR values were found in wobbler (wrwr) mice,
in Wr/HLP mice and in dystrophic mice (dydy). The most prominent ab¬
normality in the dystrophic mouse was found to be in the end-plate
structure and not in the amount of collateral branching seen. Inner¬
vation studies in Wr/HLP mice showed some similarities to the changes
seen in the wobbler mouse and suggest a lower motor neurone disease in
these mice.
7. Histological and histochemical studies of muscle were also carried
out on the gastrocnemius muscle. Measurements of muscle fibre size
suggested that the disease in the Wr/HLP mouse was a slow progressing
spinal muscular atrophy, although histochemical studies did not indicate
any fibre-type grouping.
8. Histological studies of the spinal cord were carried out to con¬
firm anterior horn cell degeneration in Wr/HLP mice and to observe
whether any changes appeared similar to those found in wobbler mice.
Some abnormalities in the motor-neurones of Wr/HLP were found, but no
conclusion could be reached as to whether the same type of degeneration
was occurring in Wr/HLP and wobbler mice.
9. The results of genetic studies as well as histological investiga¬
tions of muscle and spinal cord of the Wr/HLP mice suggest that the late
onset hind-limb paralysis disorder could result from the "wr" gene
manifesting in the heterozygote.
10. The final section of this study was carried out on human muscle.
The acetylcholinesterase-silver technique, developed for use on mouse
muscle, was modified and used on human biopsy and necropsy material.
Terminal innervation was successfully studied in muscle specimens
obtained from biopsies and from autopsies. The usefulness of this
method has been discussed.
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CHAPTER 1 - GENERAL INTRODUCTION
1
CHAPTER 1
Neuromuscular diseases have been conventionally divided into
myopathies and neuropathies. Diseases such as muscular dystrophy,
myotonic dystrophy and polymyositis have traditionally been regarded as
primary diseases of muscle with no involvement of the central nervous
system (Adams, Denny-Brown and Pearson 1962). Spinal muscular atrophy,
human lower motor neurone disease and poliomyelitis have all been con¬
sidered as primary diseases of the nervous system resulting in secondary
involvement of the muscle.
Until recently the distinction between the two categories of diseases
remained rigid, however certain clinical observations and laboratory find¬
ings have led to the suggestion that there may be a neurogenic component
in dystrophy. It has been reported that a significant proportion of
children with Duchenne muscular dystrophy are also mentally handicapped
(Zellwengar and Hanson 1967), and electrophysiological evidence has
suggested a reduction in the number of functional motor units early in the
course of the disease (McComas, Sica and Currie 1970)* However the idea
that human dystrophy may have a neurogenic origin has been seriously
questioned (Bradley 1974, Emery and Gosdon 1974).
Progress in research on neuromuscular diseases has generally been
hampered by the lack of availability during life of the tissues of primary
interest. The discovery of animal mutants with neuromuscular conditions
resembling human diseases has therefore not surprisingly aroused consider¬
able interest, in that such material can be extensively studied at various
stages during the disease process. The present study has considered two
such mouse mutants: wobbler mouse mutant, which suffers from a homozygous
recessive lower motor neurone disorder and the ReJ/l29 dystrophic mouse
which at one time was considered to have a muscle disease similar to the
Duchenne type of muscular dystrophy. These two mutants used in the study
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could classically be considered as representing a neurogenic and a
myopathic disorder respectively. The purely myopathic nature of murine
muscular dystrophy has, however, been questioned for some time. Electro¬
physiological studies have suggested defective motor innervation (McCotnas
and Mossaway 1965) and a reduction in the number of myelinated nerve
fibres was also reported (Harris, Wallace and Wing 1972). More recently
an abnormality in rayelination was demonstrated at first in the sciatic
nerve root (Bradley and Jenkison 1973) and later a similar abnormality
was found at the roots of other cranial nerves (Biscoe 1974). There is
now evidence which suggests that the primary lesion in muscular dystrophy
is not in the muscle,as was originally believed)but lies actually in the
Schwann cell. Although in man neurogenic involvement has been suggested
in both Duchenne muscular dystrophy (McComas, Sica and Currie 1970) and
myotonic dystrophy (Swash 1972), no similar aberrant myelination has been
found in those human dystrophies. On the basis of current findings,
therefore, it would be unwise to consider murine muscular dystrophy as
analogous to any human condition. It remains however a valuable model
for the study of neuromuscular disease, and the question of the inter¬
action between the nerve and muscle.
There is now little to dispute the existence of a peripheral nerve
abnormality in murine dystrophy, however, no motor neurone loss has been
found (Papapetropoulos and Bradley 1972). The primary feature of the
disease in wobbler mouse is the loss of anterior horn cells (Ouchen,
Strich and Falconer 1972)• Hence it would appear that the two mutants
used in this study should both really be considered as being affected
by neurogenic disorders, although the primary lesions lie at different
levels in the nervous system.
The dystrophic mouse mutant was first reported in 1955 (Michelson,
Russel and Harman 1955) and has been very extensively studied since.
The wobbler mouse was first observed by Falconer in 1956 but was not
described until several years later (Duchen, Falconer and Strich 1965)#
The wobbler mouse mutant has generally attracted much less attention than
the dystrophic mouse, although at present evidence suggests that the
wobbler mouse could be a useful model for the study of lower motor
neurone diseases.
It is at first difficult to comprehend why these two mutants have
attracted such a varying degree of attention among researchers interested
in neuromuscular conditions. It may be that the general lack of under¬
standing of the nature of pharmacological interactions in the central
nervous system has resulted in the wobbler mouse being studied primarily
from the histopathological angle with little consideration being given to
the biochemical or pharmacological nature of the disease process.
The complex degenerative changes occurring in the central nervous
system of mice with lower motor neurone disease have been described by
Andrews (1975) but have proved difficult to interpret as none of the
abnormalities found appear to be specific to this murine disorder. The
degenerative features found in these mutant mice appear to be specific
only in their relative frequency and distribution.
The wobbler mouse was used as a model for the study of axoplasraic
flow but the interpretation of the results obtained was inconsistent.
One study suggested impaired fast phase axoplasmic flow (Bird ^t jil^ 197l)
However another study did not demonstrate axoplasmic flow occurring at
two rates - a fast rate clearly separated from a slow rate. Rather
there appeared to be a smooth spectrum of the amount of transport occur¬
ring at different velocities and no variation of axoplasraic flow between
healthy and diseased mice of the wobbler colony was demonstrated (Bradley
Murchison and Day 1971» Bradley 1972).
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There have been very few biochemical studies of the central nervous
system in wobbler mice. The finding of elevated acid phosphatase levels
particularly in white matter of the wobbler central nervous system (Hirsch,
Andrews and Parks 1974) led the authors to consider the mutant as a model
for secondary demyelination. Increased activity of acid hydrolases have
been reported in connection with Wallerian degeneration (McCaman and
Robins 1959, Porcellati 1970). In wobbler mouse four acid hydrolases
were found to be increased in cervical cord white matter (Hirch, Andrews
and Parks 1974). Increases in lysosomal enzymes may be indirect evidence
linking enzyme activity with the presence of such features as axonal dense
bodies and myelin ovoids reported to occur in wobbler spinal cord tissue
(Andrews and Maxwell 1969). The enzyme changes observed in wobbler mice,
probably occur as the result of the degenerative process. The primary
metabolic lesion resulting in those secondary changes remains to be
elucidated.
In recent years animal material has been used extensively for the
study of numerous transmitter substances within the nervous system
(Phyllis 1970). Similar studies using human material have been limited,
although free amino-acids, several of which are believed to function as
neural transmitters, have been quantified in the CSF from patients with
neurological conditions (Perry and Jones 1961, Logothentis and Bovis 1962).
Amino-acids have also been estimated in material obtained from brain
biopsy (Perry 1971a) and at autopsy (Perry 1971b). Studies of the func¬
tion of chemical transmitters in the nervous system have resulted in cer¬
tain pharmacological agents being used in treatment of certain neurologi¬
cal conditions (Hayashi 1966» Davidoff 1970).
As the true function of pharmacological substances in the central
nervous system of healthy animals becomes better understood so such studies
can be extended to diseased material. The use of such an approach in
5
studying animal analogues of certain human conditions could prove useful
both in establishing the primary lesion and perhaps also in indicating a
possible form of treatment. Although the interaction of all the various
transmitter substances in the central nervous system are not yet fully
understood, there is considerable evidence suggesting that amino-acid
transmitters are important in the normal functioning of anterior horn
cells (Curtis, Holsi and Johnston 1968» Curtis and Watkins i960). The
loss of interneurones has been observed to result in a reduction in the
■ S
concentration of the amino-acids glycine, aspartate and glutamate in the
spinal cord (Davidoff et^ aJ 1967). In the prfesent study amino-acid con¬
centrations in the spinal cords of mice from both wobbler and dystrophic
colonies have been investigated in order to establish whether similar
amino-acid changes could also be a feature of motor neurone loss or accom¬
pany other neurological conditions.
Anterior horn cell degeneration in the wobbler mouse leads to changes
in peripheral innervation and hence to muscle atrophy (Duchen, Strich and
Falconer 1968). It has already been mentioned that these changes
resemble those which occur in human spinal muscular atrophy. An increase
in peripheral nerve branching and in the functional terminal innervation
ratio has been shown to be a feature of human SMA (Coers and Woolfel959»
Coers, Telerman-Toppet and Gerard 1973b). In human Duchenne type muscu¬
lar dystrophy no abnormality of innervation ratios has been found
(Je-drze jowska, Johnson and Woolf 1965). No detailed study of murine
peripheral innervation has until now been reported. The second part of
this study has considered peripheral innervation and end-plate morphology
in mice of the two colonies. In this part, rather greater emphasis has
been placed on mice of the wobbler colony not only because previous work
on this mutant is limited but also because of an unusual feature which
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developed in some mice of this colony. During the process of maintain¬
ing the wobbler colony, several mice were found to develop paralysis in
the hind-limbs at about the age of four months. These mice will, through¬
out the study, be referred to as Wr/HLP mice. As it was believed that
these mice could be manifesting heterozygotes (carriers) of the wobbler
gene, not only was peripheral innervation studied in these mice but also
in several asymptomatic known heterozygote mice.
Muscle histology of the Wr/HLP mouse has been compared with the
histology of affected wobbler mice and known heterozygotes as also has
the histology of the spinal cord. Hence a considerable*part of this
study has been carried out in order to eludidate the nature of the
disease in Wr/HLP mice. A limited number of genetic experiments have
also been carried out in order to establish whether the Wr/HLP mouse does
in fact represent the heterozygous state of the wobbler gene.
The major part of this study has been concerned with various aspects
of spinal muscular atrophy in mice. However, human material has also
been used in some studies in order to show how work carried out on animals
might prove useful for the study of human diseases. Most studies of
peripheral innervation in human muscle have used the vital staining tech¬
niques (Coers 1952, Coers and Woolf 1959)* These techniques require the
muscle to be very fresh, hence only biopsy material can be used. However
an acetycholinesterase-silver technique developed for the study of mouse
peripheral innervation was modified and used on both biopsy and autopsy
human muscle specimens. The results of these studies indicate that this
technique may prove particularly valuable in the study of innervation of
human muscle.





i) Processing of specimens
a) For Amino-acid analysis





1. Haematoxylin and Eosin
2. Toluidine blue





c) Stains for demonstrating Peripheral Motor Innervation
1. Acetylcholinesterase stain
2. Combined Acetylcholinesterase/silver impregnation stain
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CHAPTER 2
In this chapter the material and methods used in the study will be
outlined briefly. Methods requiring detailed explanation and the
methods used in collecting and analysing the data will be dealt with in
full in the appropriate chapters.
I. Material
Mouse specimens were used primarily for this study but work on a
few human specimens will also be reported.
i) Mouse Specimens
Three colonies of mice, bred in the Animal House of the Western
General Hospital, Edinburgh, supplied the specimens used for this study.
Details of these three colonies are given in Chapter 3* Mice from the
C57/BL colony, known to be free from any form of neuromuscular abnormality
were used as control animals in all experiments. Phenotypically healthy
and affected mice from the Bar Harbor 129 ReJ/dy and the "wobbler" (WrWr)
colony have supplied the tissues on which most of this study is based.
Spinal cord samples were used in the analysis of free animo-acid
content of cervical and lumbar enlargements. A few cords were also used
in histological preparations. Muscle samples were studied by means of
histological and histochemical techniques. The gastrocnemius muscle was
found to be most suitable for the study of peripheral innervation as
sufficient numbers of muscle fibres remained, even in highly diseased
specimens, for innervation to be studied in thick sections. This muscle
was not found to be ideal for the histochemical study of muscle5 however,
it was thought desirable to study peripheral innervation and histology on
the same muscle as different muscles may be affected to a varying degree
by the disease process,
ii) Human Specimens
Specimens of human muscle were obtained from muscle biopsies and
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from muscle taken at post-mortem examination. Very few of the specimens
received proved suitable for the study of peripheral motor innervation.
Specimens taken from various muscles have been used, as the muscle from
which any biopsy is taken depends on the disease being studied. The
deltoid muscle was used in the case of the patient with suspected lower
motor-neurone disease, in two specimens taken from known Werdnig-Hoffmann
carriers, and in necropsy specimens. The quadriceps was biopsied where
patients were affected with diabetic amyotrophy. It was found that
terminal innervation could be effectively studied in specimens obtained
up to three days after death, but in the case of muscle biopsies it was
desirable to freeze the muscle (see processing of specimen) within an
hour of operation to prevent excessive drying and shrinkage of the tissue.
II. Methods
i) Processing of Specimens
a) For Amino-acid Analysis
The animals were killed by means of ether anaesthesifc*.
The Spinal column was removed immediately. The required area
of the cord was extracted from the surrounding vertebrae with
the aid of a dissecting microscope (Leitz wefzlar) magnifi¬
cation x 6.3 using bone forceps. Care was taken to prevent
the contamination of the spinal cord with blood. The area of
the cord selected for analysis was weighed and immediately
homogenised in 1.3 ml of 10% sulphosalicylic acid at 4°C.
The sample was centrifuged at 1,500 rev/rain in a Gallenkamp
junior centrifuge (A. Gallenkamp & Co Ltd). The supernatant
was removed and stored in an ultrafreezer at -70°C; storage
was rarely for more than four hours. The time taken for
preparing the sample from the time of death of the animal to
the point of freezing of the sample was never greater than
thirty minutes.
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b) For Histology and Histochemistry
1. Muscle
Where mouse muscle was used the entire gastronemius muscle
was removed and whenever possible the muscle was directly orientated
on to the chuck either for longitudinal or transverse sections.
The muscle was secured by means of Ames compound (Ames Co., Indiana)
and frozen in isopentane chilled with liquid nitrogen. The chucks
were stored in sealed containers at a temperature of between -20°C
and -70°C until the tissue wa3 sectioned. When tissue specimens
were to be stored for more than one or two days the unmounted speci¬
men was frozen carefully in chilled isopentane and stored in sealed
tubes. The tissue was mounted on to the chuck before sectioning;
when orientating frozen specimens on to the chuck care had to be
taken to prevent the defrosting of the tissue. Frozen muscle
specimens could be stored in well sealed tubes for up to a year with¬
out marked changes in muscle histology. Human muscle specimens
were prepared for sectioning in the same way.
Sections were cut in a Slee retracting microtome (Slee Co Ltd),
o o
maintained at a temperature of between -25 C and -20 C and the
sections were attached on to glass slides at room temperature.
Transverse sections for use in histological and histochemical pre¬
parations were cut at a thickness of 10p whereas longitudinal sec¬
tions for use in preparations for the study of peripheral innerva¬
tion were cut at thicknesses of between 20^1 and 5QM for mouse specimens
and between 5and 100y» for human specimens. Sections of less
than 3Op thickness were dried at room temperature. Sections of
over 3Qju in thickness were dried in a current of cold air to prevent
tissue shrinkage resulting from rapid drying. Sections of lOOp in
thickness were not mounted very satisfactorily in this way and it
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was found more appropriate to mount the section after previous
fixation (for details see appendix).
2. Spinal Cord
Spinal cord specimens of either cervical or lumbar enlarge¬
ment, whichever was not being used for amino-acid analysis, were
frozen as outlined for muscle. All spinal cord specimens were
mounted for transverse sections. These were cut at 20u thickness
and fixed directly on to glass slides,
ii) Staining Techniques
a) Histological Stains (Carleton 1967)
1) Haematoxylin and Eosin (Muscle and Spinal Cord)
Muscle was stained for 2 minutes in haematoxylin and
30 seconds in 1% eosin, whereas spinal cord specimens required
3 minutes in haernatoxylin and 15-20 seconds in eosin.
2) Toluidine Blue (Spinal Cord)
- Fix fresh frozen sections 1 hour in formol saline
- Rinse well in distilled water
- Stain 1% toluidine blue in 1% borax at 56°C for 1 minute
- Differentiate in 95% ethanol
- Dehydrate clear and mount.
3) Combined Luxol Fast Blue Cresyl Violet (Spinal Cord)
- Fix fresh frozen sections 1 hour in formol saline
- Stain overnight in 1% luxol fast blue in 95% alcohol
and 5% acetic acid
- Wash in distilled water
- Differentiate 5-10 seconds in 0.05% aqueous lithium
carbonate
- Continue differentiating in several changes of 70%
alcohol until grey matter can be distinguished from
white
- Rinse well in distilled water
- Stain for 6 minutes in 1% cresyl violet to which
5 drops of 10% acetic acid per 30 ml were added before
use
- Rinse in distilled water
- Differentiate in 96% alcohol
- Dehydrate,clear and mount.
4) Gomori-frichrome (Muscle)




The method used was Barka's modification (Barka and
Anderson 1963) a method developed by Scarpelli (Scarpelli, Hess
and Pearce 1958)* A stock solution was made up containing all the
constituents except NaDH (see appendix); water was substituted for
the NaDH solution. This stock solution could then be stored inde-
o . 0
finitely at -20 C. The solution was stored in aliquots of about
2 ml, thus a small amount of the solution could be thawed as required
and NaDH was added just before use to give a final concentration of
approximately 1 mg/ml. Slides were dried for 15 minutes to prevent
the sections becoming detached from the glass, and were then incu¬
bated in the above solution for one hour at 37°C. Control sections
were incubated in the same solution from which NaDH was omitted.
After incubation the slides were rinsed in distilled water and
placed in acetone for 5 minutes to remove unreduced tetrazolium. .
The sections were mounted either in 100% (w/v) aqueous polyvinylpy-
i-rodine medium, as described by Burstone (1957) or in glycerine
mountant.
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2) Calcium-activated Myosin ATPase (Muscle)
A method for the localization of phosphatases was first
described by Gornori (l94l) and the method for studying myosin ATPase
activity in situ has been developed from this. The basis of the
method used in this study was described by Padykula and Herman (1955)
with the modification that the 0.1 M sodium barbitone solution has
been substituted by 0.1 M Tris.
For demonstrating myosin-ATPase activity at pH 4.3i the sections
were pre-incubated for 10 minutes in Walpole's acetate buffer then
rinsed in distilled water before being treated in the same way as
slides for regular rayosin-ATPase staining at pH 9»4. They were
incubated for 40 minutes into the substrate solution at 37°C (see
appendix). The sections pre-incubated at pH 4.3 often proved more
successful than regular ATPase staining at a pH of 9*4 as at the
lower pH, a surface precipitate and the wrinkling of tissue often
obscured the true fibre-type; this could have been prevented by
using an incubation medium of pH 9»3 containing 0.04 Mcalcium
(Brooke and Kaiser 1969)•
c) Stains for Demonstrating Peripheral Motor Innervation
Specimens of mouse muscle were stained directly using the
combined acetylcholinesterase/silver technique. Human muscle speci¬
mens, where it was necessary to assess whether the sample being
studied did encompass the motor point, were first stained with
acetylcholinesterase alone to demonstrate the presence of end-plates,
l) Acetylcholinesterase Stain (Muscle)
A stain for demonstrating acetylcholinesterase activity
in muscle was described by Koelle and Friedenwald (1949) and there
are several methods in use at present (Pearse 1972). The method
used in this study is outlined in the appendix.
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2) Combined Acetylcholineaterase/silver Impregnation Stain
Silver impregnation techniques for peripheral innervation
studies were first demonstrated by Palm^gren (19&Q)• Methods com¬
bining the visualisation of acetylcholinesterase activity with
silver impregnation of the axons are now in common use. The method
used in this study most closely resembles the one described by
Namba (Namba, Nakamura and Grob 196?)• The method is given in
detail in the appendix. It has proved successful for use on both
human and mouse tissue although certain adjustments were made for
sections of lOOp thickness.
CHAPTER 3 - CLINICAL AND GENETIC STUDIES
I. Introduction
II. Material and Methods
i) Material
ii) Methods









3.1 The breeding experiments set up to test the genetics of
Vr/HLP Mice
3.2 The correlation between increased birth weight and age in
Wr/IILP Mice and healthy controls
3.3 The results of genetic observations on wobbler and dystrophic
colonies
3.4 Data on the genetics of Wr/HLP Mice
3.5 Evidence to support the hypothesis that Wr/HLP Mice are carriers




Mice of the wobbler colony have not proved difficult to breed;
however, the number of homozygous affected animals born has been shown
to be significantly below the expected 25% of all animals born to proven
heterozygous carrier parents (Duchen, Strich and Falconer 1968). From
the original data on this colony the low percentage of 'wobbler' mice
cannot be explained by an enhanced pre-weaning mortality. It has,
however, been suggested that the available data on the disease pathology
of wobbler mice, could also be compatible with other mechanisms of patho¬
genesis, with the role of the genetic factor being a contributory one
rather than exclusive (Andrews et al 1974). The neuronal vacuolariza_
tions reported in degenerating anterior horn cells of wobbler mice is a
non-specific phenomenon which accompanies abnormal states of widely vary¬
ing aetiology. It has therefore been suggested that in the'wobbler'
mouse the genetic factor may be responsible for an enhanced vulnerability
or an unusual response to an infectious agent or perhaps an atypical
response to some other form of insult. Such an explanation would to
some extent resolve the problem of the number of affected animals born
to mice believed to be heterozygous for the condition, without the neces¬
sity of using prenatal mortality of animals as the explanation. Mice of
the wobbler colony consistently have reasonably large litters and a num¬
ber of affected animals may survive for a year or more, hence prenatal
mortality would appear unlikely in a condition which is relatively benign.
No infectious agent has however been found in affected wobbler mice
(Andrews crt ad 1974), hence on present data one has to conclude that
murine lower motor neurone disease is a homozygous recessive disease, but
for some reason at present not understood, the number of affected animals
born is somewhat below the expected value.
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The purpose of this study has been to reassess the data on this
colony and to compare the results previously reported with those obtained
whilst a wobbler colony has been maintained at the Western General
Hospital in Edinburgh* These results of breeding experiments using the
wobbler colony have also been compared with those of the ReJ/129 dystrophic
colony, as murine muscular dystrophy is also a homozygous recessive dis¬
order and both colonies were maintained under identical environmental
conditions.
In the process of studying the wobbler colony, the survival of
affected animals was also observed. As has been mentioned, wobbler mice
may survive for over a year (Duchen, Strich and Falconer 1968), although
such a life-span is the exception rather than the rule, the condition
more generally terminates in death at about three to five months of age.
Such variability in survival in a condition believed to be caused by a
single gene defect is difficult to interpret. In the human, spinal
muscular atrophy has been classified into several conditions depending
on age of onset, mode of inheritance and the rate at which the disease
progresses (Emery 1971)• In order to determine whether the disease
occurring in the mouse is a single pathological condition, the life-spans
of all affected animals within each sib-ship have been compared. The
variability of life-spans in affected mice from the dystrophic colony
were also observed, although in general the maximum life expectancy of
dystrophic mice is not believed to be greater than six months (Michelson,
Russel and Harman 1955)*
The animals affected with both murine dystrophy and lower motor
neurone disease are small in size compared with the healthy animal and
this is due to small skeletal size and not solely to reduced muscle mass.
It has, however, been shown that in the case of the dystrophic animal
birth weight is not indicative of the likelihood of any animal being
16
affected (Harman jat aL 1963)• Similar experiments have not been carried
out on mice of the wobbler colony and it is not known whether birth
weight or the growth rate of these animals up to a point of showing
clinical symptoms could act as an indicator of early changes. In this
study1 therefore, birth weights and growth rates of mice from the wobbler,
C57/BL, and dystrophic colonies have been observed.
During the course of maintaining the wobbler colony a phenomenon
not previously reported was noticed in some of the mice. Several
animals showing no disease symptoms early in life, developed a severe
hind-limb paralysis at between four to five months of age. Hind-limb
paralysis has been reported to occur in some mice with lower motor neurone
disease, but onset was three weeks post-natally and the normal features
associated with wobbler mice were also present in these animals (Harris
1975)» whereas, in mice with the late onset of hind-limb paralysis the
fore-limbs did not appear to be greatly affected. The clinical symptoms
and genetics of the Wr/HLP mouse have been studied and will be discussed
in the light of all the unusual findings associated with the wobbler
colony.
II* Material and Methods
i) Material
The material on which the entire study is based has been obtained
from two mutant mouse colonies, the ReJ/l29 dy colony and the wobbler
colony. Control data has been derived from studying mice of the C57/BL
colony, as these animals are known to be free of neuromuscular disease.
Although numerous strains of mice could have been used as control material
the original 'wobbler' mutation occurred in an inbred strain of C57/BL Fa
mice and was transferred to a non-inbred C57/BL background (Duchen, Strich
and Falconer 1968). The study has been concerned primarily with mice of
the wobbler colony as many of the clinical aspects of the disease in these
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mice have not been clearly established. Clinical and genetic data on
mice of ReJ/129 dy variety is readily available but some studies have
also been carried out within this programme, primarily to monitor environ¬
mental conditions and to act as a control colony for genetic studies on
mice of the wobbler colony,
ii) Methods
a) Animal House procedure
All the mice used in the study have been maintained under identi¬
cal environmental conditions. Mice were caged with six to eight animals
per cage, affected animals however were kept with only one or two litter-
mates.
Wood shavings were used as the bedding and nesting material. The
bedding was changed twice weekly, the cages were washed and autoclaved
at least once a month. The animal diet consisted of Spratt's small
animal diet no 1 (Spratt Patent Ltd, Barking, Essex), a supplement of
grain mixture consisting of maize and oats was given twice weekly. A
slice of fresh cucumber was placed daily into all cages where affected
animals were present in order to prevent animals from becoming dehydrated,
when they had difficulty in reaching the water bottles. Water was
changed daily and the water bottles were washed thoroughly once a week.
The room temperature was maintained at between 21-25°C. The animals
were not however provided with an artificial light cycle; in winter,
daylight hours were supplemented with electric lighting in the afternoons.
The cages were checked daily for births, deaths, etc.
Ten breeding pairs for each of the mutant colonies and three C57/BL
pairs were maintained at any one time. Both murine dystrophy and lower
motor neurone disease are homozygous recessive disorders, hence matings
were set up using littermates of affected animals. The breeding pairs
were tested for heterozygosity by allowing each pair to have a minimum
eighteen sibs. If none of the animals from these sibships showed
disease symptoms by six weeks of age, the breeding pair was discarded.
Originally when such a pair was discarded all its offspring were also
removed. However, after the original observation that some mice in
the wobbler colony began to show abnormal features at four months of age
all animals of this colony were observed until they were a minimum of
six months old. A number of animals showing symptoms of hind-limb
paralysis were also used for breeding purposes. These matings will be
described in detail under the section covering genetic studies.
A number of other mouse colonies, eg Peruvian, Bar Harbor obese,
Balb C, Swiss white, CBA/CA, were kept under identical environmental
conditions. No animals from these colonies showed any symptoms similar
to those observed for the Wr/HLP mice, nor was any infection noted in the
animal house during the period that the wobbler colony was under
observation.
b) Clinical Studies
The age of onset of clinical symptoms of disease was recorded
for mice of both the wobbler and dystrophic colonies. All animals of
the wobbler colony were also observed at regular intervals for symptoms
of hind-limb paralysis. The age of onset of this syndrome in a mouse
was also recorded. The progress of the disease and life-spans of all
affected animals were also noted.
Animals from a total of eight litters born to mice of the wobbler,
C57/BL, and dystrophic colonies were weighed daily from birth to weaning.
Four wobbler litters and two from each of the other colonies were studied.
Also a number of animals were weighed twice weekly from weaning until six
months of age. The animals chosen for the second part of the weighing
study were invariably the younger sibs of animals which were affected
with hind-limb paralysis. C57/BL mice were also weighed as controls.
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As muscle wasting invariably leads to some loss in weight it was impor¬
tant to establish whether weight loss was due to loss of muscle bulk or
whether it preceded the onset of clinical symptoms.
Several other tests were devised in the hope of establishing a means
of recognising Wr/HLP mice before the onset of Clinical symptoms. Mice
were observed climbing up the trellising of the cage when it was held
vertically. Attempts at establishing muscle strength were made by
hanging a mouse on the edge of a tall beaker and timing how long it
clung before falling. Mice were also twisted vigorously by the tail
and then the time that the animal required to recover a normal posture
was recorded. Such tests have previously been useful in distinguishing
both wobbler and dystrophic mice from their healthy litteriaates before
the clinical symptoms are fully developed.
c) Genetic Studies
The data on the dystrophic colony was obtained over a period of
two and a half years. Records of all matings were maintained together
with the offspring that each produced. The number of affected animals
and the pre-weaning mortality was carefully recorded.
The wobbler colony was set up at the Western General Hospital in
Edinburgh in 1973 from eight pairs donated by Muscular Dystrophy Research
Laboratories in Newcastle-upon-Tyne. This colony has, therefore, now
been maintained for two and a half years and similar data was recorded
as for the dystrophic colony.
In October 1973 some mice with an unusual hind-limb weakness were
noticed in the wobbler colony. As the disease did not resemble any
that result from an infectious agent and no environmental cause for the
disorder could be established, certain breeding experiments outlined in
Table 3»1 were set up. A full scale breeding programme could not be
carried out as there was not enough material available at the time that
this study was begun.
TABLE 3.1










Wr/HLP x + Wr/HLP 5 - - -
Wr/HLP x + WrWr/Wrwr 3 38 3 -
Wr/HLP x ° Wrwr 3 54 1 16
WrWr/Wrwr x + Wr/HLP 3 27 - -
Wrwr x + Wr/HLP 1 12 2 -






The most characteristic early manifestations of murine dystrophy
are the dragging of the hind legs, followed by a progressive paralysis of
the hind-lirabs; the fore-limbs are not affected to the same extent and
movement is maintained by the mouse using its fore legs* The pectoral
muscles become degenerate and the mouse assumes a hunchback appearance.
Often the eyes become infected and close. This is probably as a result
of poor grooming. A dystrophic mouse is illustrated in Plate 1.
The clinical symptoms of the wobbler mouse arise at about the same
age as those of the dystrophic mouse, between three and four weeks after
birth. The earliest recognisable feature being that of a fine tremor
followed by muscle wasting primarily in the fore-limbs. The mouse is
seen to have an unsteady gait and becomes unable to extend the fore-paw
at the wrist, hence it is ultimately seen to walk on the dorsum of the
paws* Both wobbler and dystrophic mice are seen to be smaller than
healthy littermates from about the fourth week of age, but the disparity
in size is somewhat greater in wobbler mice. The wobbler mouse is
illustrated in Plate 2 .
It was mentioned in the introduction to this study that mice showing
a hind-limb paralysis were observed in the wobbler colony. The earliest
symptoms of this syndrome arise four to five months after birth. The
mouse develops a slight tremor and is seen to have difficulty supporting
itself on its hind-limbs. At very early stages of the disorder it is
difficult to ascertain whether in fact the animal is diseased as there
is a day to day variation in the severity of both tremor and of the visible
weakness of the hind-limbs. As the disease progresses the abnormality
becomes very striking with considerable wasting of the pelvic muscelature
and progressive paralysis of the hind-limbs; occasionally paralysis of
the tail is also seen with the tail being permanently inclined forward.
The fore-limbs remain comparatively unaffected particularly during the
early stages of the disease process. However at about eight months,
wasting of pectoral muscles can be seen and in the terminal stages of
the disease there is in fact little to distinguish the Wr/HLP mouse from
a wobbler mouse of about the same age, although paralysis of tail muscles
in the wobbler mouse is unusual. Wr/HLP mice are illustrated in Plate 3.
The animals weighed at birth from each of the three colonies were
between 1.2-1.8 grams. The average weight for animals from an individual
litter depended primarily on litter size rather than on the colony of ori¬
gin. The growth rate of mice from birth to weaning also depended pri¬
marily on litter size; it was found that during this part of the study
several mice from wobbler litters died before weaning or very soon after,
and although no wobbler mouse was diagnosed in any of the litters studied,
the mice that died may have been affected. Wobbler mice do not stand up
to stress very well and the daily weighings would have amounted to a form
of stress. No pre-weaning deaths were encountered in litters from the
C57/Bb end dystrophic colonies. The mice from the wobbler colonies that
did die appeared to lose weight one or two days prior to death. A much
larger number of litters would be required to establish exactly the stage
in their development at which growth becomes obviously stunted. However,
at weaning the affected wobbler mouse is often the smallest of a litter^
the difference in weight between healthy littermates and wobbler mice are
rarely greater than 1.5 grams. At four weeks, however, affected animals
weigh 6-8 grams, whereas healthy animals weigh between 16 and 19 grams.
At four months affected animals weigh around 15 grams, and healthy litter¬
mates and C57/BL mice of the same age weigh between 25-35 grains. The
differences are not found to be as great for the dystrophic colony.
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Many animals from one wobbler colony were weighed twice weekly,
three of which developed the late onset hind-limb paralysis. When
the weights of these animals were compared with those of healthy litter-
mates and C57/BL animals it was found that all fell well within the normal
range for any given age, until the point at' which muscle wasting was
clearly visible. When growth rates were compared for the entire period
that the animals were studied healthy animals showed a significant corre¬
lation between age and weight which was not found for Wr/HLP mice. When
only the period after symptoms had occurred in Wr/HLP mice was used for
statistical analysis, a significant correlation was found between the loss
in weight and increase in age; no similar result was found for the healthy
animals. The results are given in Table 3*2. These results indicate
that the loss in weight is primarily due to loss of muscle bulk. The
weight of mice could not be used as an indicator of the likelihood of a
particular animal developing late onset muscle disease.
The attempts to assess developing muscle weakness by considering the
climbing ability or clinging ability of the animal proved of little value
as even affected animals were able to climb quite successfully. The
hanging experiment proved only that the animals do not like being subjected
to this form of stress and it is difficult to get the animal to cling to
the edge of the beaker. Furthermore no two hanging times for a single
animal showed any correlation.
One test, however, did prove useful, in confirming that an animal
showing the earliest symptoms of weakness was in fact affected with the
hind-limb paralysis disorder. After a mouse is vigorously twisted by the
tail it invariably takes 13-30 seconds to recover and to begin using its
limbs normally. However, it was found that Wr/HLP mice may take up to
two minutes to recover and as they do so they often move backwards. This
sort of backward movement is not frequently seen in healthy animals.
TABLE 3.2
Correlation between the increase in weight with age in
Wr/HLP and healthy controls
Age in days X P
Healthy Animals 1 58 - 214 0.8159 <0.001
(WrWr/Wrwr) 2 58 - 189 0.8951 < 0.001
3 58 - 189 0.9455 <0.001
Affected Animals 1 58 189 O.1321 NS
(Wr/HLP) 2 58 - 214 -0.0432 NS
3 58 - 214 -0.0994 NS
Healthy Animals 1 154 214 -O.6138 < 0.02
2 154 - 189 -0.4527 NS
3 154 - 189 0.8231 < 0.01
Affected Animals 1 154 189 -0.8767 < 0.01
2 154 - 214 -0.8764 < 0.01
3 154 - 214 -0.8832 < 0.01
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In neurological diseases of mice the hind-limbs frequently become
flexed and adducted instead of extended when the animal is raised by the
tail. Although this is occasionally true for Wr/HLP mice, however, the
test of lifting the animal by the tail cannot be used as a diagnostic
procedure for the Wr/HLP mouse.
Several tests have been devised in an attempt to recognise Wr/HLP
mice pre-clinically, particularly to enable more extensive genetic studies
to be carried out; however none of the tests have been useful in estab¬
lishing a method for early diagnosis, though some of the tests have proved
useful in confirming early clinical symptoms,
ii) Genetic Studies
The results of the genetic studies are given in table 3*3*
The results indicate that wobbler mice account for only 13.6% of total
births from heterozygote breeders, however dystrophic mice account for
24.4% which is remarkably close to the 25% expected for a homozygous
recessive disorder. The low numbers of wobbler mice cannot be accounted
for by an increased pre-weaning mortality as the total percentage of pre-
weaning deaths is the same for both wobbler and dystrophic colonies.
These results confirm Falconer's earlier observations on the wobbler
colony (Duchen, Strich and Falconer 1968).
The observations of the life-span of wobbler mice have shown that
no genetic factor is involved in determining the rate of progress of the
disease process in affected mice. It would appear that all affected
animals undergo trauma shortly after weaning; those that do survive may
live up to twelve months. Affected animals from an individual litter
usually live for nearly the same number of days but this is not true of
affected animals from an entire sibship. It would therefore appear that
some environmental factor, as well as the litter size, determines the
life-span of affected animals. Similar findings were also made on the
TABLE 3.3
The results of genetic observations on the wobbler and dystrophic colonies
Total %
no. of hetero- Total Total pre-weaning Total affected
Colony breeding zygote births mortality animals
Pairs Pairs no. % no. %
Wobbler 56 37.6 1105 111 10.0 185 18.6
Dystrophic 47 44.7 723 73 10.1 162 24.4
In the wobbler colony the number of affected animals is significantly
different from the expected value 2 Qx = 35*Oo P^ O.OOl
TABLE 3.4
Data on the genetics of Wr/HLP
Type of Mating No. Offspring
WrWr + Wrvr wrwr Wr/HLP Total
Wrwr x Wrwr 17 750 169 22 941
Wr/HLP x WrWr 1 5 - 11 16
Wr/HLP x Wrwr 3 37 16 - 53
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dystrophic mice, although these mice were not as vulnerable at weaning,
whilst their maximum survival time was no greater than eight months.
Attempts to study the genetics of Wr/HLP mice have proved difficult
because of the late onset of this disease and the small litters produced
by affected animals. The results are given in Table 3*4.
The results have to be assessed using three hypotheses: firstly
that the disease is an unusual manifestation of that occurring in wobbler
mice; secondly that the heterozygote 'Wrwr' occasionally shows symptoms
of a lower motor neurone disease which manifests itself in late onset
hind-limb paralysis; and thirdly that the wobbler and hind-limb paralysis
diseases are not connected genetically.
If the first hypothesis were true, the percentage of affected animals
would increase to 22%. However, this is an unlikely explanation as
Wr/HLP mice have occurred in litters where no wobbler mice have been diag¬
nosed. Also an affected Wr/HLP female mated with a male, homozygous for
the doftuvant'Wr'gene has resulted in offspring with hind-limb paralysis.
There is evidence, however, that the second hypothesis may be true.
A known heterozygote male when mated with a female showing hind-limb
paralysis resulted in offspring showing the normal symptoms of wobbler
mice. Further evidence for this hypothesis comes from a particular pedi¬
gree shown in Table 3»5« From this pedigree it would appear that the
probability of hind-limb paralysis being associated with the •Wrwr' genome
is 72.3%t whereas the probability that this is not so is 27»7%» The
results were calculated by the Bayesian method. Although the results
are by no means conclusive because of the very small numbers involved,
they are useful as an indicator for further study.
Not all heterozygote animals however show clinical manifestations.
Moreover, histological studies on muscle and peripheral nerve (see
chapters 5 and 6) confirm that many are free from any gross degenerative
TABLE 3.5
Evidence to support the hypothesis that Wr/HLP mice are carriers
of the 'vr' gene
PR12 - The animals mated PR x PR
were obtained from 6 8
no. of offspring 57
no. of wrwr
no. of Wr/HLP
PR26 PR x PR
12 12
no. of offspring 39
no. of wrwr -
no. of Wr/HLP 1
PR35 PR x PR
26 26/HLP
no. of offspring 8
no. of wrwr -
no. of Wr/HLP
pR46 PR x PR
6 35
no. of offspring 45
no. of wrwr 5
no. of Wr/HLP 3
PR12
Genotypes Wrwr x Wrwr Wrwr x W'rVr WrWr x WrWr
Prior Probability v* V, v9
Posterior Probability (?)57 (1)57 (I)57
Joint 0.0000000336 0.4444 0.1111
Re1."Probability is 0 0.80 0.20
.*. Probability that any offspring is Wrwr = £(0.80) + 0(0.20) = 0.40
PR26
Prior Probability 0.16 0.48 0.36
Posterior Probability (*)39 (I)39 (I)39
Joint 0.00000215 0.48 0.36
Rel. Probability 0 0.57 0.43























changes other than those associated with ageing. It may therefore be
the case that an epistatic gene is involved and the loss of the epistatic
gene leads to the disease phenomenon.
All mice which have had offspring with hind-limb paralysis disease
were directly related to Pair 8 which was one of the original pairs
obtained from Newcastle. In addition 47-5% of the total Wr/HLP mice
diagnosed were obtained from five brother/sister matings, whereas the
remaining 52.5% of the mice were born from a further ten matings.
Inbreeding would enhance any genetic abnormality such as the loss of an
epistatic gene. Perhaps epistatic interaction could be useful in
explaining the wide spectrum of severity of the disease in wobbler mice
as well as the occasional occurrence of gross hind-limb involvement in
murine lower motor neurone disease (Harris 1975)*
The attempts to breed two Wr/HLP mice have proved unsuccessful,
although such matings would have been very useful in determining the
true genetic nature of this disease.
IV. Discussion
The study of the wobbler mouse from clinical and genetic aspects
has confirmed earlier findings (Duchen, Strich find Falconer 1968), that
the numbers of affected animals born falls short of the 25% level expected
for a homozygous recessive disorder.
This shortfall cannot be accounted for by post-natal mortality,
hence the deficiency must presumably be ascribed to pre-natal mortality.
As the wobbler mice do show a lot of variability in the severity of the
disease, perhaps some mice are very grossly affected and die before birth.
It is, however, difficult to interpret the findings that diseased animals
may live up to a year but over fifty per cent die before the age of two
months. The wobbler mouse was firstly suggested as a model for human
spinal muscular atrophy of the Werttoig-Hoffmann type, but was later
considered more in terms of an analogue for the Kugelberg-Welander
disease because of the slow progress of the disease in the mouse. It
would appear, however, that in the mouse this disease varies widely in
severity. This does not appear to be genetically determined and for
this reason perhaps it would be more useful purely to consider the mouse
as a useful tool in the study of lower motor neurone disease rather than
to consider it as an analogue of any human disorder.
The disease occurring in the Wr/HLP mouse creates further problems
in interpretation. The results of the preliminary genetic investigations
on this disorder suggest that Wr/HLP mice are manifesting carriers of the
'wr' gene. However the clinical symptoms in this disorder are very
different from those of the wobbler mouse in that not only is the disease
late in onset but different muscles appear to be involved. Manifesting
carriers do occur in human Duchenne dystrophy (Moser and Emery 197*0 5
however this is an x-linked condition and the variable abnormalities seen
in these carrier females ranging from a barely raised creatine phosphokinase
level to that of considerable weakness in hind-limb muscles is easily
explicable by the Lyon hypothesis (Lyon 19&2).
There are examples in human diseases where the heterozygous carriers
of a homozygous recessive disease show symptoms. Sickle cell haemoglobin
occurs to a variable extent in carriers of the sickle cell gene and the
amount of sickling is dependent on such factors as the blood group of the
patient and the amount of foetal haemoglobin present. Hence the system
of epistatic genes, which form an integral part in the genetics of blood
groups, determines the range of symptoms seen in the heterozygote (Giblett
1969).
Late onset hind-limb paralysis has not previously been described in
mice of the wobbler colony, although Harris' (1975) study has demonstrated
a few wobbler mice with gross hind-limb involvement. From results of
electrophysiological studies he has suggested that the phenomenon is due
to an unusual distribution of muscle weakness rather than a separate
disease entity. Although only one such mouse has been found in our
colony it is possible that the same epistatic gene is involved in the
late onset diesase and the unusual distribution of muscle weakness in
the occasional wobbler mouse.
There is, however, a further possible explanation for Wr/HLP mice
which cannot bo entirely disregarded. A form of hind-limb paralysis
similar to that shown in the Wr/HLP mouse has been shown to occur in mice
as a result of Type C RNA virus infection. This infection, resulting
in lower motor neurone disease, has an age of onset in the wild mouse of
about four months. Paralysis is of the hind-limbs, the fore-limbs
remaining relatively unaffected. This disease, however, is of a much
shorter duration than that occurring in Wr/HLP (Gardner et al 1973)•
It is unlikely that the same virus would be responsible for the two
diseases, but further investigations are required to eliminate the possi¬
bility of a viral agent being involved in the disease of Wr/HLP mice.
The data given in this study is compatible with the hypothesis that
the Wr/HLP mouse is a possible carrier of the 'wr* gene and that a
possible loss of an epistatic gene results in the manifestation of
disease symptoms.
PLATE 1
a) An affected dystrophic mouse with a healthy littermate
Age 4 months





a) An affected wobbler mouse with a healthy littermate
Age 2 months






a) and b) Both show a Wr/HLP mouse. Age 6 months.
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Free amino-acids are found in most tissues of the body as they serve
as precursors for, and are the products of, protein metabolism. There
are, however, certain tissues where a number of amino-acids are found in
concentrations considerably higher than would be expected if the function
was purely to participate in the amino-acid pool for protein metabolism.
The tissues of the central nervous system have been found to contain
particularly high concentrations of certain amino-acids such as glycine,
aspartate, glutamate and glutamine (Tallan 1962). These amino-acids are
also found in varying concentrations in other tissues, however, ^-amino-
butyric acid (GABA) which appears in concentrations of between 1.5 and
6.0 micro moles per gram wet weight of brain tissue of all vertebrates
is only found as a constituent of the nervous tissue. This would suggest
that GABA and perhaps other amino-acids such as glycine and aspartic acid
have a specific function within the central nervous system.
The development of the technique of iontrophoresis, which has enabled
a drug to be placed directly into the extracellular environment of a
single nerve cell (Nastuk 1953) has resulted in the identification of
numerous pharmacological substances which influence neuronal excitability
(Curtis & Watkins i960, Curtis 1964). Two groups of structurally related
amino-acids have been shown to influence neuronal activity when administered
in the proximity of the cell. Several monocarboxylic "^-amino-acids
related to glycine have a potent depressant effect on neuronal excitability
(Curtis & Watkins I960) whereas a number of acidic amino-acids related to as¬
partate have been shown to exhibit a pronounced excitatory effect on nerve
cells in various regions of the brain and spinal cord (Curtis, Phyllis &
Watkins i960, Curtis & Watkins 1963)* A table indicating the structure-
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activity relationship of some excitant and depressant amino-acids is
given in Table 4.1. Not all the amino-acids shown in the Table are
found in the nervous tissue, whereas others only occur in minute concen¬
trations. Those that are normally found in such concentrations that
they can easily be measured have been indicated. They are, firstly,
taurine, glycine and GABA which, when topically applied in the vicinity
of the neurone have a depressant effect on that cell, and secondly, aspar¬
tate and glutamate which on iontrophoretic administration result in
neuronal excitation. Glutamine has also been found in high concentra¬
tion in the brain and spinal cord (Tallan 19&2, Graham et al 19f>7)»
Glutamine does not influence neuronal excitability, however the metabolism
of glutamine and glutamic acid are closely related.
There is some evidence that the five amino-acids - glutamic acid,
aspartic acid, glycine, taurine and GABA - may function as transmitters
within the nervous system. Nevertheless, the mere demonstration of a
pharmacological substance having an effect on neurones does not irrevo¬
cably establish it as a transmitter.
In 1966 Werman set out certain criteria which he considered as the
essential requirements to be satisfied by any substance before it could
be defined as a neural transmitter. These are that the compound must
be present in the nerve ending; the corresponding synthesizing system
should be present in the neurone where the transmitter is believed to
function; there ought to be a mechanism for termination of action of
the compound; the compound should be released into the extracellular
fluid when the neurone has been stimulated and, lastly, the action of
the transmitter suspect must be identical in every way to that of the
neural transmitters.
As GABA is an amino-acid found uniquely in the central nervous sys¬

































































































































& Watkins 1959» Roberts & Eidelberg I960, Tsukada et^ al^ 1963, Kravitz
1967)* The action of GABA on spinal motor-neurones was shown not to be
affected by strichnine (Curtis, Phyllis & Watkins 1959)* It was believed
that inhibition by GABA was not accompanied by membrane hyperpolarisation
(Curtis & Watkins 1965)5 this led to the suggestion that GABA had a non¬
specific depressant activity on motor-neurones. It has since been demon¬
strated that GABA Inhibition is accompanied by membrane hyperpolarisation,
however not strychnine but picrotoxin and bicuculline are the specific
inhibitors of GABA activity (Curtis, Hosli & Johnston 1967» Precht &
Yoshida 1971$ Curtis et al 1970). As strychnine effectively prevents
the action of inhibitory transmitter on motor-neurones (Curtis & Watkins
1965)« it is unlikely therefore that GABA is the transmitter responsible
for hyperpolarising strychnine antagonised post-synaptic potentials of
motor-neurones. Evidence is accumulating to suggest that GABA is not
the primary inhibitory transmitter in the spinal cord; however it does
appear to function in that capacity in other areas of the brain. Parti¬
cularly well substantiated is the evidence that GABA functions as a
transmitter in the substantia nigra, where the concentration of this
amino-acid is higher than in any other area of the brain (Obata 1972,
Okada & Hassler 1973)* It has been demonstrated that cerebral cortex
takes up radioactive GABA from external media leading to a large net
increase of the amino-acid in the tissue (Inverson & Neal 1968).
As GABA is important in the central nervous system it is unfortunate
that by the methods used in the present study it was impossible to esti¬
mate GABA concentrations in the spinal cord of mice. The purpose of the
study, however, has been the investigation of concentrations of amino-
acids in the spinal cord of wobbler mice, where the disease process is
known to result in the loss of motor-neurones. GABA is the amino-acid
least likely to be affected by such a disease process. It has been
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demonstrated that mechanical damage to the cord which results in loss of
interneurones affects the concentration of various amino-acid transmitter
suspects but does not affect GABA concentration (Davidoff et al 1967)*
There is plenty of evidence to show that glycine functions in the
cord as an important inhibitory transmitter. Glycine distribution within
different areas of the cord conforms with that expected for a post-synaptic
inhibitory transmitter (Graham et al 1967). A high affinity uptake sys¬
tem for glycine has been demonstrated (Neal & Pickles 1969), and it has
been suggested that this high affinity uptake system significantly contri¬
butes to the inactivation of synaptically released glycine at spinal inhi¬
bitory synapses (Johnston & Inversen 197l)« The accumulation of glycine
in the region of the synaptosomes was observed autoradiographically
(Matus & Dennison 1972). The uptake of radioactive glycine by the cord
has been shown to be two to six times that of the telencephalon (Aprison
& McBride 1973)• There is also little doubt that the action of glycine
on the motor-neurones is identical with that of the natural occurring
inhibitory transmitter (Werman, Davidoff & Aprison 1968, Phyllis 1970).
It was demonstrated by Davidoff in 19&7 that glycine is associated
with the interneurones in the spinal cord. When the spinal cord is
damaged by surgical procedures, glycine, glutamic acid and aspartate
concentrations are reduced; however, neither GABA nor glutamine are
affected. The concentration of both glycine and aspartate have been
shown to be directly correlated with the number of interneurones in the
cord. A comparative study of various areas of spinal cord from seven
different vertebrates has revealed that there is a higher concentration
of glycine in regions of the cord supplying the nerves to limb muscula¬
ture. In animals such as the snake where there are only vestigal limbs
the concentration of glycine is the same along the whole length of the
spinal cord, whereas the bird has a high concentration in the cervical
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cord with high lumbar glycine being found in jumping animals such as the
caimen (Aprison, Shank & Davidoff 1969). In order to establish glycine
as the inhibitory post-synaptic transmitter in the spinal cord, in accor¬
dance with criteria set down by Wermau, all that would be necessary
would be the collection of the compound at the synaptic region in amounts
proportional to the rate and extent of stimulation of the pre-synaptic
nerve. Electrical stimulation in vitro does result in amino-acid
release (Hammerstad, Murray & Cutter 1971). Glycine as well as GABA,
taurine and glutamic acid are all released and there appears to be no
regional specificity. Such an experiment cannot be entirely satisfactory
as selective stimulation of a single synaptic pathway is almost impossible,
hence, considering that many pathways are stimulated, the results of
release experiments are difficult to interpret. The evidence that
glycine is of considerable importance in the spinal cord is, however,
sufficient to warrant an interest in its possible significance in lower
motor neurone disease.
L-aspartic acid and L-glutamic acid have been postulated as the
excitatory transmitters. Aspartate distribution in the different areas
of the cord is in line with that expected for a polysynaptic excitatory
transmitter (Graham et al 1967). Glutamate distribution is compatible
with it being an excitatory transmitter at the terminals of primary
afferent fibres (Duggan & Johnston 1970). A high affinity uptake system
has been demonstrated for these two amino-acids (Logan & Snyder 1971i
1972). Although there is further circumstantial evidence to suggest
transmitter function for aspartate and glutamate, the excitatory amino-
acids have not been as thoroughly investigated as the possible inhibitory
transmitters. Aspartate has been shown to be associated with interneurones
(Davidoff «rt jal 1967) and its concentration in cat spinal cord rises
markedly during tetanus intoxication, possibly due to the increased
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activity of excitatory spinal interneurones (Balcar & Johnston 1973)•
The activity of glutamate at crustacean synapses has been more extensively
studied than its function in the vertebrate nervous system and there is
evidence that in Crustacea,glutamate does function in an excitatory
capacity (Johnston 1972). It is possible that the same is true for
neurones in the spinal cord. Glutamic acid diethylester reversibly
blocks excitation evoked in the spinal cord and other areas of the brain
and it is a more effective antagonist of glutamate induced neuronal
activity than of excitation produced by other amino-acid transmitters
(Haldeman & McLennan 1972).
Taurine is the only other amino-acid found in high concentrations
in spinal cord and shown to influence neuronal excitability (Curtis &
V>atkins I960)* This amino-acid is also found in fairly high concentra¬
tions in other tissues and this is especially true for the mouse. Never¬
theless, taurine has been found in nerve-ending particles isolated by
centrifugation and within the particles there was also an enzyme for
taurine synthesis (Kaczmarek, Agrawal & Davison 1970). Furthermore,
taurine uptake by brain slices resembles that for GABA and glycine and
it would also appear that taurine is released into extracellular fluid
on stimulation of the rat cortex (Kaczmarek & Davison 1972). There is
little further evidence; the distribution of taurine has not been studied
and no specific inhibitor of taurine activity has been found. It has
been suggested that taurine may function as a modulator influencing
neuronal activity but not dependent on synaptic transmission. On pre¬
sent evidence, however, this hypothesis has little to support it or
reject it.
As has already been mentioned, glutamine,although not associated
with neuronal excitability, is nevertheless found in high concentrations
in spinal cord. Glutamine and glutamate are metabolically closely
related in nervous tissue and the concentrations of the two amino-acids
have been found to be approximately equal in the ventral cord but in the
dorsal cord the glutamate concentration is rather higher (Graham _et al
1967).
There are numerous other free amino-acids and several dipeptides
found in the brain. The cerebral content of free amino-acids is labile
and highly responsive to circumstances which affect body conditions.
Subjecting an animal to malnutrition or excessive temperature would
result in changes in some amino-acid profiles in the brain (Mcllwain &
Bachelard 1971)• A progressive disease such as is seen in the wobbler
mouse could influence the metabolic state of the brain and spinal cord.
The purpose of this study has been to investigate changes in trans¬
mitter suspect amino-acids in cervical and lumbar cord in two mutant
mouse colonies, the first being the wobbler mouse where involvement of
motor-neurones in the disease process has been well established (Duchen,
Strich & Falconer 1968, Papapetropoulos & Bradley 1972) and in the dyst¬
rophic mouse where abnormalities in peripheral nerve have been reported
(Bradley & Jenkison 1973)1 but there is still no universal agreement as
to whether the disease is of a neurogenic or myopathic origin. Both
diseases result in loss of muscle function although in the wobbler mouse
the fore-limb is affected more than the hind-limb, whereas the reverse is
true in the dystrophic mouse.
As the study of amino-acid transmitters was carried out by column
chromatography, other amino-acids and ninhydrinpositive substances present
could also be estimated, and the results of some of these have also been
reported.
II. Material arid Methods
i) Material
The cervical and lumbar enlargements of mouse spinal cord were
analysed for free aroino-acid content. Mice from the wobbler, dystrophic
and C57/BL colonies were used. The number of samples from each of the
groups of animals for both cervical and lumbar cord analysis are given
in Table 4.2. Mice from the C57/BL colony were used as controls and
their ages ranged from 48 to 268 days. The wobbler and dystrophic
mutants were of varying ages showing the spectrum of severity of the
disease. The healthy animals from the wobbler and dystrophic colonies
were, whenever possible, littermates of the diseased animal but where no
littermate was available an age-matched animal from the same colony was
used.
In this study no animals from the wobbler colony showed any signs
of the late onset neuromuscular disease described in Chapter 3«
The spinal cords of three C57/BL mice were pooled for the analysis
of the coefficient of variation of the chromatographic technique. For
the same purpose a pooled amino-acid standard (Sigma) was also used.
ii) Methods
a) Preparation of Sample
The method for the preparation of spinal cord samples for amino-
acid analysis is given in Chapter 2, page 8 . Just before the sample
was to be used it was allowed to thaw at room temperature. To 1 ml of
the sample 0.1 ml of norleucine standard (BDH chromatographically homo¬
genous norleucine diluted to 0.1 u moles/ml) was added.
The three C57/BL spinal cords were prepared in the same way, but
they were homogenised in 10 ml of 10% sulphosalicylic acid. After cen-
trifugation 9 ml of the supernatant was removed and to it was added 0*9 ml
of the norleucine standard. The sample was then aliquoted to give
TABLE 4.2 - The Animals used in the Experiments
Strain





1 C57/BL control 9 9
2 DyUy/Dydy healthy 10 7
3 dydy diseased 10 7
4 W rW r/Wrwr healthy 9 8
5 wrwr diseased 8 7
TABLE 4.3 - The Amino-acids found consistently in spinal cords
No. Amino-Acid No. Araino-Acid
1 Cysteic Acid 9 Glycine
2 Phosphoethanolamine* 10 -alanine
3 Taurine 11 Ornithine
4 Aspartic Acid 12 Hysine
5 Threonine 13 Histidine
6 Serine 14 Homocarnosine•
7 Glutamine 15 Arginine
8 Glutamic Acid
* No. 2 - Phosphoethanolamine only estimated in cervical region
* No.l4 - Homocarnosine and carnosine form one peak but most of
the peak probably due to homocarnosine
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individual samples of 1.2 ml* The aliquots were frozen and stored at
o
-70 C. One ral of each sample was used for araino-acid analysis.
The amino-acid standard (Sigma Ltd) was prepared by diluting the
commercial preparation by one in twenty-five with distilled water and
1.2 ml samples were stored at -70°C. Again, each sample was used for
analysis.
b) Amino-acid Analysis
The free amino-acid content of the spinal cord samples was anal¬
ysed by means of ion exchange chromatography using a single column
gradient elution technique (Emery et al 1970). The technicon NCI model
autoanalyser was used which incorporates a column of 140 cm in length,
0.6 cm diameter. The sodium citrate buffer system was used. The
ninhydrin reagent, which was maintained under an atmosphere of nitrogen
to prevent oxidation, was made up freshly once a week.
c) Calculation of Amino-acid Concentrations
In calculating the concentrations of the individual amino-acids
in a given sample, the peak area obtained for the known concentration of
standard is compared with the peak area for each of the amino-acids in
that sample. Not all amino-acids react in exactly the 3ame way with the
ninhydrin, hence a correction has to be made for the celourimetric inten¬
sity with which each amino-acid reacts with the reagent. Assuming the
standard norleucine has an activity of 1 for a concentration of 0.1 u moles/
ml, using the same concentration of each amino-acid one can calculate how
the amino-acid reacts with the ninhydrin as compared to the activity of
the standard. This value is known as the norleucine equivalent value
(NLE).
i) nle Area under peak of 0.1 u moles/ml norleucine
Area under peak of 0.1 u moles/ml of a.a.x
For a sample where concentration of x is unknown:
. Area under peak of a.a.x „„ „11) Cone, in u moles/ml of x =». ' . — . x NLE x 10.Area under peak of norleucine
This value was then converted to micromoles per gram wet weight of
the spinal cord specimen. A slightly different method is used for cal¬
culating concentrations of amino-acids where two amino-acids form one
peak. Here one uses the peak areas obtained for the two amino-acids at
a wavelength of 570 X and 440 This method results in some inaccuracy
where both amino-acids are of near equal concentrations. Using a sodium
citrate buffer system glutamine and asparagine elute as one peak as do
glutamic acid and proline. In spinal cord there is virtually no aspara¬
gine or proline and one could almost assume that peaks were made up
entirely of glutamine and glutamic acid as both these amino-acids occur
at high concentrations in the spinal cord. All calculations of amino-
acid concentrations were carried out on the Olivetti calculator,
d) Statistical Analysis
The coefficient of variation was obtained for each of the amino-
acids in the standard solution (Sigma Ltd) and for each amino-acid in
the pooled spinal cord specimen. The average coefficient of variation
was calculated for both methods.
The method was able to detect twenty-eight amino-acids, a list of
which is given in the Appendix; several occur in the spinal cord at
concentrations too low for reliable calculation. Fourteen amino-acids
occur in most spinal cords at concentrations which can be easily measured
and these have been used in analysing differences between the various
mice. A list of the fourteen amino-acids are given in Table 4.3«
The coefficient of variation of several amino-acids has been calcu¬
lated for the individual groups of mice and compared with the coefficient
of variation for the machine.
Regression analysis was carried out for amino-acid concentrations
on the age of the mouse for all the groups of animals. Student^
t test was used to compare amino-acid concentrations in male and female
mice of the control group of mice.
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III. Results
i) Coefficient of Variation for the technique
The average coefficient of variation calculated using the standard
was 6.7% whereas using the pooled spinal cord sample it was 2.5%* The
coefficient of variation using the same technique on samples of amniotic
fluid gave a value of 5% (Emery ejt jal_ 1970) •
ii) Coefficient of Variation of Amino-acids in the Mice
The coefficient of variation for seven of the araino-acids was cal¬
culated for each group of mice for both regions of spinal cord studied:
it was noticed that in most cases the coefficient of variation of indivi¬
dual amino-acids for the mice was greater than that observed for the
technique. The results suggest considerable variability of amino-acid
concentrations in the spinal cord within all the groups of mice. Regres¬
sion analyses have shown that there is no significant regression on age,
nor is there a significant difference between the results obtained for
the two sexes. There also appears to be a greater variability of cer¬
tain amino-acid concentrations in mice from the two mutant colonies than
is seen for the C57/BL mice.
iii) Analysis of Ammo-acid Concentrations in the Mice
a) Cervical Region
The concentrations of amino-acids in cervical cord of control
mice, wobbler mice and dystrophic mice are given in Table 4.4. It is
interesting to note that all the amino-acids which differ significantly
from the controls are possible transmitters with the possible exception
of horaocarnosiae. Glutamine which has no effect on neuronal firing
appears to be of much the saute concentration in all the animals studied.
b) Lumbar Region
The concentrations of amino-acids in the lumbar cord for the
three groups of animals is given in Table 4.5.
TABLE 4.4
Amino-acid concentrations in cervical cord of control (C57/BL),
wobbler (wrwr) and dystrophic (dydy) mice
Results expressed as moles/gra wet weight (Mean - SD) and the
significance of the differences between affected animals and controls
Controls Wobbler P Dystrophic P






































































































Amino-acid concentrations in lumbar cord of control, wobbler and
dystrophic mice
Results expressed as p moles/gm wet weight (Mean - SD), and the
significance of the differences between affected animals and controls
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In the lumbar region very few amino-acids differ statistically from
those found in the controls. In the lumbar region aspartic acid is
increased in the wobbler mice, whereas in the cervical region this amino-
acid concentration is lower in animals of the two mutant colonies. Horoo-
carnosine is increased in the wobbler; it is similarly increased in the
cervical region.
The concentrations of amino-acids obtained for the littermates of
the affected animals are given in the Appendix. The littermates
are not entirely valid as controls as they are of unknown genotype.
iv) Analysis of Amino-acid concentrations in each of the
Mutant Colonies
a) The Wobbler Colony
When comparing statistically the results obtained for the
affected animals and their littermates, the aspartic acid level in the
cervical cord was found to be significantly reduced in the affected
wobbler mice P^O.Ol, whereas homocarnosine was raised in the cervical
cord P<0.01 and the lumbar cord P<,0.05»
b) The Dystrophic Colony
In the dystrophic colony there appears to be little difference
between the affected animal and the littermates. Homocarnosine is
slightly increased in the lunfoar region of the affected animal but this
is not reflected as a difference between the dystrophic mouse and the
C57/BL mouse.
IV. Discussion
The results from the study of amino-acids in the spinal cords of
mice from the C57/BL, wobbler and dystrophic colonies have proved rather
more complex than was originally expected. It was believed that if
differences in amino-acids did occur they would be between healthy and
diseased animals regardless of the colony from which the healthy mice
originated. The results that have been obtained make any interpretation
rather difficult. It could be suggested that variation between the
strains of mice used in this study may account for the differences in
amino-acid concentrations obtained for the C57/BL mice and those of the
two mutant colonies. If this were the answer one would expect
differences occurring between C57/BL and wobbler mice to be somewhat less
than those between C57/BL and dystrophic mice. The wobbler mice origi¬
nated as a mutation in an inbred strain of C57/BL mice whereas the dyst¬
rophic mice are a Bar Harbor strain. A further suggestion may be that
inbreeding affects the physiology of the spinal cord of these mice. Both
these suggestions may be in part correct; they do not, however, explain
the extent of the differences in the concentrations of the amino-acids
aspartate, glutamate and glycine between cervical regions of C57/BL mice
and those of the wobbler and dystrophic mice. Several studies of brain
amino-acids and a study of spinal cord glycine in various mammalian species
have shown that the differences in concentrations between species are often
less than those occurring between the strains of mice (Tallan 1962, Aprison,
Shank & Davidoff 1969).
Loss of neurones from affected wobbler mice have been reported to
be greater from the cervical region than from other regions of the cord
(Papapetropoulos & Bradley 1972). It has also been shewn that a loss of
interneurones from damaged areas of the cord results in a reduction of
aspartate, glutamate and glycine concentrations (Davidoff jst al^ 1967)*
The low concentrations of these amino-acids in the cervical cord of
wobbler mice may, therefore, be interpreted as being the result of the
loss of neurones from the cord. The lumbar region asparate level is,
however, raised above that of C57/BL mice even though some neurones are
also lost from the lumbar cord in this mutant. This hypothesis fails
to explain the amino-acid differences occurring between C57/BL mice and
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the healthy littermates of the wobbler mice, in which motor-neurone loss,
if any, is of a lower order than that occurring in affected mice. It
in no way accounts for the raised homocarnosine levels occurring in both
cervical and lumbar regions of most affected mice, nor can it explain
the similarities in amino-acid concentrations occurring in mice of both
wobbler and dystrophic colonies. There is, however, the possibility
that two degenerative processes may result in similar changes in spinal
cord amino-acids, but the low levels of certain amino-acids occurring
in mice of both wobbler and dystrophic colonies cannot be explained in
terms of motor-neurone loss.
It may be of greater significance to consider further the differences
found in amino-acid profiles between the mice of the wobbler colony and
the dystrophic colony. It has already been mentioned that the results
of this study indicate that homocarnosine in the wobbler affected mouse
cords is significantly elevated. In the cervical cord of mice from the
dystrophic colony, taurine as well as glutamate, aspartate and glycine
appears to be reduced. The profiles for amino-acid concentrations in
dystrophic lumbar cord do not differ from those of the C57/BL mice,
however there are some differences between C57/BL mice and dystrophic
littermates for this region of the cord. Whether these variations in
the healthy mice should be considered as a further abnormality or purely
as a compensatory phenomenon resulting from differences in amino-acid
distributions is not certain. In resolving this problem it may have
been more useful to study the complete spinal cord of these mice. There
has been a report suggesting that biochemical changes involving Kreb's
cycle non-ketonic acids of various tissues including the brain are more
readily reflected in heterozygotes than in horaozygote affected mice of
the dystrophic colony (Montalbo & Kabara 1974). In another study, the
steady state and rate of turnover in the brain of a putative neurotrans-
raitter, acetylcholine, has been shown to be reduced in affected animals
when compared with phenotypically normal mice; however, no reduction
was seen in the steady state or rate of accumulation by the brain of
k-aminobutyric acid (Trabucchi jrt al_ 197't). It is not certain whether
these results would also apply to the spinal cord. The results from
this study indicate that further clarification of the role of neurotrans¬
mitters in murine dystrophy is required. Any further study should
include genotypically normal as well as phenotypically normal and diseased
animals from the dystrophic colony. It would also prove useful if
various areas of the brain and spinal cord were assessed for amino-acid
content and the active uptake by these tissues of certain transmitter
suspects were studied.
In considering the results obtained in mice of the wobbler colony,
a possible approach may be to look at them in the light of present knowledge
of the effects of malnutrition on the nervous system. There is consi¬
derable evidence that malnutrition in both humans and animals results in
neurological changes (Piatt & Stewart 1971» Manocha & Olkowski 1973)•
These include tremor of the head, apathetic behaviour and stiffness and
uncoordination of movement. Changes of this nature are not altogether
surprising as although brain cells are not actively dividing the protein
turnover of healthy nervous tissue is very high. Malnutrition leads to
a change in the amino-acid profile of the blood, whereas many amino-acids
found in the brain and spinal cord are taken up from the blood against a
concentration gradient (Balcar & Johnston 1973)? hence the reduction in
concentration in the blood of any of these amino-acids would be rapidly
reflected in the nervous tissue. Malnutrition in monkey results in a
marked accumulation of histidine, 3-niethylhistidine and horaocarnosine in
the brain, and associated with those changes are further marked distor¬
tions of other free amino-acid profiles (Enwonwu & Worthington 1973)•
A protein-calorie deficient diet in monkey resulted in changes in all
three areas of the brain that were studied (Enwonwu & Worthington 197*0 •
Thus in the cerebrum, cerebellum and brain-stem, the amino-acid and two
dipeptides already mentioned are increased, whereas two probable excita¬
tory transmitters, L-glutamate and L-aspartate, are found in reduced con¬
centrations; however, taurine, threonine and serine concentrations are
also decreased. The amino-acid glycine and GABA appear to be remarkably
unaffected by malnutrition. The amino-acids in the spinal cord, under
conditions of mainourishment, have not been investigated. It would
appear probable, however, that some of the changes mentioned above would
also be reflected in the spinal cord. The results obtained from mice
of the wobbler colony are not entirely consistent with those found in
malnutrition in the monkey; however, one must take into account that
different areas of the nervous system have been studied and that there
may be variation between the specific changes that are likely to occur
under the same conditions in monkey and mouse. In the cervical region
of affected mice there is a marked increase in homocarnosine and a loss
in aspartate, the concentrations of these two ninhydrin-positive substances
being significantly different not only from the C57/BL control mouse but
also between the affected mouse and its littermate. It would appear
possible, therefore, that there may be a similarity between some of the
biochemical changes occurring in malnutrition and those occurring in
affected wobbler mutants. It has been suggested that neurones adapt
to the changed environment of malnutrition by utilising structural pro¬
teins for their metabolism (Manocha & Olkowski 1973)* Such changes would
inevitably lead to a loss of neurones and it is a loss of motor-neurones
from the spinal cord that characterises the disease process in the wobbler
mouse. This study has produced insufficient evidence to either support
or reject such a suggestion. It may be useful, however, if amino-acid
changes in mouse brain and spinal cord were studied under conditions of
malnutrition and if further amino-acid analyses were carried out on the
brain of healthy mice and mice with hereditary motor-neurone disease.
Throughout this study it has been assumed that the increase, in both
cervical and lumbar cord in the wobbler mouse, is in the dipeptide homo-
carnosine even though it has been shown by Enwonwu, and confirmed using
our amino-acid analyses, that homocarnosine and carnosine are recorded
as one peak (Enwonwu & Worthington 1973)* Homocarnosine is, however,
found exclusively in tissues of the central nervous system, whereas car¬
nosine which is primarily found in muscle, occurs in central nervous
tissue in very low concentrations (Abraham, Pisano & Udenfriend 1961,
1962). There are suggestions that it is the same enzyme that synthesises
both carnosine (p-alanyl-L-hinline) and homocarnosine (^-aminobutyl-L-
histidine), and competition between ^-alanine and GABA for the same
receptor-site on the enzyme carnosine synthetase has been shown (Skaper,
Das & Marshall 1973)* There is, therefore, a very close relationship
between these two dipeptides in nervous tissue. In mouse carnosine has
been found in high concentration in the olfactory bulb and this has led
to the suggestion that carnosine is a potent neuroinhibitory substance
in this area of the brain (Neidle & Kandera 197'*)« Horaocarnosine is
also suspected of being a neuroinhibitor. By using homocarnosine on
both epileptic dogs and epileptic humans it has been demonstrated that
homocarnosine is a special neuroinhibitory substance associated with
seizures in the limbic motor system (Hayashi 19&5* 1966)• It would
appear that whether the increase be of horaocarnosine or carnosine it
would have a marked effect on the central nervous system. An increase
in either dipeptide accompanied by a decrease in aspartic acid, a pro¬
bable neuroexcitatory amino-acid, could possibly result in membrane
hyperpolarization of susceptible motor-neurones, resulting in their mal¬
function and eventual degeneration.
The results of this study have neither proved nor disproved an
association between the disease phenomena in dystrophic or wobbler mice
and changes in concentrations of transmitter amino-acids. It would
appear, however, that the dipeptide, homocarnosine or carnosine, may in
some way be linked with hereditary lower motor-neurone disease in mouse.
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In recent years the improvement in techniques for histological
preparations of peripheral nerve (Page 1970 and 1971) has been a contri¬
buting factor to the understanding of peripheral motor innervation in
both man and animals.
Many human studies have primarily concentrated on distinguishing
innervation changes occurring as a result of neuromuscular disease
(Coers and Woolf, 1959? MacDermot 1961; Jedrzejowska, Johnson and Voolf
1965; Allen, Johnson and Woolf 1969) and on quantifying the extent of
ramification of the terminal axon in both healthy and diseased muscle
(Coers, Reske-Nielson & Harmsen 1970; Coers, Telerman-Toppet & Gerard
1973a & b).
In 1959 Coers and Woolf defined the terms "actual terminal
innervation ratio" (ATIR) and "functional terminal innervation ratio"
(FTIR).
ATIR is defined as the ratio of the number of motor end-plates
arising from a given number of terminal axons to that number of axons,
whilst FTIR is defined as the ratio of the number of muscle fibres
innervated by a given number of terminal axons to that number of axons.
• No. of motor EP arising from x terminal axonsATIR = " 1 11
x
r>«-rn No. of muscle fibres innervated by x terminal axons
rTXK 3= " 1 1 L.« j 1 j 1 1 1 1 1 1 1 i II I. ii m m j 1 . I I « I ii . I II -li 1 11 .1
X
The difference in these two ratios is that, whereas ATIR is a
measure of the overall sprouting from the terminal axon, FTIR is a
measure of collateral innervation in response to partial denervation.
The study of these two ratios in normal and diseased muscle has
proved useful in distinguishing between innervation changes resulting
from damage to the lower motor neurones and other neurogenic changes
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perhaps secondary to a myopathy. The study of the FTIR may be particu¬
larly useful where a distinction between a neuropathy and a myopathy may
be difficult to establish purely on the basis of a histological and
histochemical assessment of the muscle (Black et al 1974).
Mice have been used extensively in the study of neuromuscular
disease (Banker & Denny-Brown 1959! Curtis, Abramas & Harman 1961;
Meier I969K Innervation in diseased muscle has been studied using
both histological techniques (Harman et al 19^35 Duchen, Strich &
Falconer 1968) and electrophysiology (Mclntyre, Bennett & BradFey 1959?
McCoraas, Mrozek & Thomas 1968). No quantitative study of the functional
terminal innervation in mouse muscle has been attempted, although it
has been suggested that in murine muscular dystrophy the ATIR may be
raised with the FTIR remaining normal (Harman et aT 19&3)* Neither has
there been any study of innervation in phenotypically healthy animals,
which are obligatory heterozygotes for the gene associated with a neuro¬
muscular disease. It was believed that the study of the functional
terminal innervation ratio in mice of both the wobbler and dystrophic
colonies would add to an understanding of the two hereditary murine dis¬
orders. It was also felt that such an approach to the study of murine
muscular dystrophy in the light of present knowledge, which suggests a
neurogenic component in this disease (Bradley and Jaros 1973? Bradley
and Jenkison 1973)» may be useful in resolving the controversy as to
whether functional denervation is a feature of the disease and whether
the condition closely resembles a primary neurogenic rather than myo¬
pathic disorder (Bradley 1971! Harris & Wilson 1971j Harris & Marshall
1973} Emery & Gosdon 1974; Law & Atwood 1974).
Changes in peripheral innervation which do not occur as a direct
result of lower motor neurone disease or surgical denervation may not
necessarily be reflected by an increased or reduced functional terminal
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innervation ratio. Structural abnormalities of the subterminal axon
or the motor end-plate may be more prominent. Changes in the myoneural
junction as a result of disease have been studied mainly by means of
electronmicroscopy. Dystrophic end-plates of both the 129 ReJ/dy mice
2J
and dy mice have been shown to be abnormal (Ragab 1971; Gilbert,
Steinberg & Banker 1973)* There has, however, been a light microscopy
study on growth and degeneration of motor end-plates in hind-limb muscles
of cats of varying ages (Tuffery 1971)• Mouse innervation and end-
plate structures have been studied in muscles derived from animals with
hereditary motor end-plate disease (Duchen 1970) and from animals previ¬
ously treated with cardiotoxin (Duchen et al 1974). Although light
microscopy has been employed for studies of mouse motor end-plates,
under disease conditions, the changes in structure of the terminal
arborizations occurring as a result of disease have not been previously
quantified; nor have the types of end-plates found on muscle in healthy
mice been classified. This study has used a similar system for the
classification of end-plates to that suggested by Tuffery in his study
of cat motor end-plates. The size and structure of end-plates in
muscle from mice of varying ages and from each of the three colonies:
the C57/BL, the wobbler and the dystrophic - were examined. The aim of
the present study was to consider whether mouse nerve endings were
affected by an ageing process similar to that described in cat (Barker
and lp 1965; Tuffery 1971) and to establish whether end-plate morphology
in heterozygotes from either the wobbler or dystrophic colonies differed
from that of control mice.
By studying both the innervation ratio and the variation of end-
plate structure in the same muscle sample, it was hoped to establish
how peripheral innervation in mice was affected by the wobbler and dys¬
trophic genes and so obtain a better overall understanding of the effects
of the two diseases on peripheral innervation.
49
II. Material and Methods
i) Material
The gastrocnemius muscle from a total of forty-one mice was used
for the analysis of terminal innervation and motor end-plate morphology.
Specimens from C57/BL mice aged between 80 and 274 days were compared
with phenotypically healthy and affected animals from the dystrophic
and wobbler colonies. Specimens from mice of the wobbler colony with
a late onset hind-limb paralysis were also used in this study. The
numbers of mice in each group are given in Table 5«1«
ii) Methods
a) Preparation of sample
The animals were killed by ether anaesthesia. The whole gastro¬
cnemius was removed, frozen in liquid nitrogen and prepared for longi¬
tudinal sections as described in Chapter 2, page 9 • Sections of between
20-50 y. were cut and placed directly on to a slide. Extra caution was
taken when drying sections of above 30 p thickness. The slides were
placed in a current of cool air to prevent excessive shrinkage of tissue.
Sections of diseased wobbler muscle were cut at between 20-40 p thickness
whereas other samples were cut at between 40-50 p thickness.
b) Methods for staining
Slides were stained using the combined acetylcholinesterase/
silver technique detailed in the Appendix. Sections which were less
than 40 u in thickness did not require the full two hour fixation in
o
formal calcium; between one and one and a half hours was sufficient.
It was also noticed that to obtain appreciable acetylcholinesterase
activity in muscle from wobbler affected mice it was necessary to
increase the time of incubation in substrate solution from the two
minutes used normally to 4-5 minutes.
TABLE 5.1




























c) Method for assessing innervation
Stained preparations were observed using a Leitz Orthoplan
Microscope (Leitz Optics Ltd) at a magnification of x(625). The length
of the terminal axon was measured to the nearest 25 }i using a calibrated
graticule inserted into the eye piece. The method used in the study of
terminal innervation was based on the one used for human muscle (Coers,
Telerman-Toppet & Gerard 1973a). Certain adjustments were made to
allow for the fact that mouse axons are considerably shorter than those
found in human muscle; hence, whereas Co&rs suggests that only axons
greater than 200 yi in length should be included in the analysis, in this
study axons of 100 p in length and above have been used. All the axons
measured were required to end in a terminal arborization on a muscle
fibre; axons or branches of axons not seen to end in an end-plate were
disregarded for the purpose of this study. Axons branching to give two
end-plates on a single muscle fibre were treated in the same way as
unbranched axons. Axons which branched collaterally, terminally or
ultraterminally resulting in the innervation of more than one muscle
fibre were all noted regardless of the total length of the axon.
In the majority of preparations a total of between forty and sixty
axons could be used for the assessment of the FTIR. In specimens of
wobbler mouse muscle the preparation was often such that no innervation
ratio could be calculated whereas in others the ratio had to be based
on small numbers of axons as very few met the specifications enabling
them to be included in the calculation.
d) Method for calculation of results of terminal innervation studies
The FTIR was calculated using the formula given in the
Introduction, page 46. FTIR was calculated for each of the mice studied
and a mean FTIR for each of the groups of mice was obtained. The results
are given in Table 5-2. The results for the animals in no way affected
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with a neuromuscular disease were then pooled and analysed for the
correlation between the increase in FTIR on age, and the mean FTIR for
healthy animals was also calculated.
e) Methods for the study of motor end-plates
used for terminal innervation studies.
1. Size
The terminal arborization was located on a muscle fibre by
its cholinesterase activity intensified with silver, as outlined in the
staining method (see Appendix). The area of cholinesterase activity
was assumed, for the purpose of this study, to represent the area of
the motor end-plate. The longest diameter of this area was taken to
be a reasonable estimation of end-plate size. The motor end-plates
measured were all represented by a clearly defined area of cholinesterase
activity, and were seen to be the termination of a motor axon, situated
on a muscle fibre. This method of measuring the motor end-plates in
acetylcholinesterase/silver stained preparations has various limitations.
The intensity of staining of the motor end-plate is dependent on the
cholinesterase activity in the area, which in turn depends on the time
that the tissue is exposed to the substrate. Silver precipitation
around the area of activity may be an additional cause of inaccuracy.
Furthermore, the orientation of the tissue may not be entirely longi¬
tudinal and the end-plate not centrally placed on the muscle fibre, thus
not exposing the entire length of the motor end-plate. It has also
been suggested that the size of the subterminal apparatus should be
related to the muscle fibre size (Zacks 1964). In this study only mean
end-plate sizes were estimated for individual mice and for each of the
groups of animals. Wherever possible the mean end-plate size was esti¬
mated from 100 measurements although in diseased animals, when fewer
End-plate studies were carried out on the same preparations
end-plates were present, numbers were often smaller. Magnification
used for measurement was x 625, and lengths were recorded to the nearest
4 ji.
2. Structure
End-plates were classified into different categories accord¬
ing to their structure. The guidelines for such a classification were
suggested by Tuffery (l97l)» The *T' number T 1-5 indicates the number
of myelinated branches from the axon that contribute to the formation
of a single end-plate. Such end-plates may be divided again into those
that are just T , T , etc, and those that also have a 'sprout', defined\ G*
as a non-myelinated outgrowth typically ending in a growth cone, or a
'contribution', a non-myelinated outgrowth ending not in a growth cone
but in an axon terminal on the same sole-plate as those of their parent
endings. A further type of end-plate can be distinguished: that of a
'duplex'. 'Duplex' innervation is defined as two branches of a single
axon lying on separate sole-plates but on the same muscle fibre. Two
hundred end-plates was the maximum number studied from any one specimen
although in some poorer preparations and in samples from diseased muscle
as few as 80 end-plates could be classified. In many of the samples
numerous sprouts could be seen but it was difficult to decide from which
axon they were branching or to see where the growth cone terminated.
For this reason it was decided to consider sprouts only if they were
nodal and appeared to be growing towards the muscle fibre on which the
original end-plate was situated. In this way the emphasis on end-plate
structure was maintained. Some of the end-plates classified may have
been in various stages of degeneration but the degeneration of end-plates
was not considered in this study.
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f) Method for calculating results of end-plate studies
1. Size
The mean end-plate size was calculated for each specimen.
The mean sizes for each group of animals were compared with the mean
sizes for control C57/BL mice using Student's -t test. All mean
end-plate sizes for healthy animals were pooled and a correlation of
size with age was calculated. The mean end-plate sizes for affected
mice were further compared with healthy animals from the same colony.
2. Structure
The number of end-plates in each of the categories outlined
in section (e.2) was calculated as percentages of the total number of
end-plates studied for each specimen. A mean percentage of end-plates
within each category was calculated for the different genotypes. The
percentages of end-plates classified into each of the following categories:
*T ', 'T0', 'T ' and 'T + contribution' for the control mice, were com-1 & J 1
pared by Student's -t test to the percentages occurring in each of the
other groups. The results for percentages of *T • end-plates from all
the phenotypically healthy animals were pooled and a correlation analysis
of age with the percentage 'T ' end-plates was calculated. The
Student's -t test was also used for comparing the mean percentage of




Table 5*2 indicates the mean FTIR for each group of mice. The
mean FTIR for all healthy animals taken both from the C57/BL mice and
littermates of affected mice has been found to be 1.04 with a standard
deviation of 0.02. Using the criteria for the upper limit of normal
as the mean - 3 SD, the range for normal terminal innervation results
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can be given as O.98 to 1.10. There is, however, a small but signifi¬
cant correlation between FTIR and age (r = 0.562 P -<0.02). The mean
terminal innervation ratio for all of the affected groups of animals
was above the range for healthy individuals. The degree of terminal
branching appeared to be least prominent in dystrophic mice and most
obvious in the wobbler mice. The results for Wr/HLP mice were also
high, the values lying between the controls and wobbler mice. The
normal terminal innervation and innervation in animals of the affected
groups is illustrated in Plates 1-4.
a) The wobbler colony
1. Phenotypically healthy animals
The FTIR of all phenotypically healthy animals, whether they
were known to be heterozygotes for the wobbler gene or not, have termi¬
nal innervation ratios falling well within the normal range. The
evaluation of FTIR does not therefore appear to be a method for distin¬
guishing between genotypically normal and mice heterozygous for the *wr'
gene. The results are given in Table 5»2. Other features of innerva¬
tion such as demyelination of axons and axonal degeneration without
collateral branching have not been studied in detail. There does not
appear to be any variation between innervation in C57/BL mice and pheno¬
typically healthy animals of the wobbler colony with the possible excep¬
tion of two animals, whose FTIR although still falling within the normal
range appear to be somewhat above the value expected for that age of
mouse. The individual results of FTIR are given in the Appendix. It
is probable that the two results mentioned indicate a pre-clinical state
of HLP.
2. Mice with hind-limb paralysis (Wr/HLP)
The results of terminal innervation ratio in these mice give
little indication of a reason for paralysis, especially when one
TABLE 5.2
The Results of Functional Terminal Innervation Ratios (FTIR)
FTIR 0, ...
_ . SignificanceGenotype No. ^ SD ^ n<>oial
C57/BL 6 1.03 0.02 -
WrWr/Wrwr 6 1.05 0.02 NS
Wrwr 4 1.05 0.02 NS
Wr/HLP 7 1.20 0.05 P< 0.001
wrwr 7 1.64 0.30 P< 0.001
DyDy/Dydy 4 1.04 0.01 NS
dydy 5 1.12 0.01 P< 0.001
Using all healthy mice to obtain mean FTIR
Mean = 1.04 SD = 0.02
Hence using M - 3SD as representing the normal range
normal range = O.98 - 1.10
TABLE 5.3






C57/BL 6 30.7 1.1
WrWr/Wrwr 6 30.2 1.0
Wrwr 4 30.7 0.8
Wr/HLP 7 31.1 2.0
wrwr 7 26.6 3.3
DyDy/Dydy 4 29.2 1.6
dydy 5 32.1 1.6
55
considers that in the wobbler mice the FTIR is much higher for the same
muscle and yet no paralysis was seen in hind-limbs in any of the wobbler
mice studied. The study of FTIR alone, however, does not give an ade¬
quate indication of the considerable abnormalities found in innervation
of muscles in these mice; numerous fine fibres are seen both in the
proximity of a group of sub-terminal axons, and wandering 'aimlessly'
through the muscle. Although some of the fine fibres are found to be
'beaded' most do not show this characteristic of regenerative fibres
(see Plate 2 ). The intramuscular nerve bundles have a mixture of
normal appearing axons with some fine fibres, the number of normal axons
becoming reduced as the disease progresses. There appeared to be an
overall loss of axons in these mice; however, no count of intramuscular
nerve fibres was attempted and the apparent loss of axons may be decep¬
tive. The numbers of normal fibres is reduced with the substitution
by fine fibres of a much smaller diameter. Some indications of deray-
elination of axons are seen, and nodal, subterminal and terminal sprout¬
ing are unmistakable features of innervation in this condition. In
early stages of the disease, however, many areas of normal innervation
can still be found. Such areas of normal innervation have not been
seen in wobbler mouse muscle even in very young animals. Innervation
in Wr/HLP is illustrated in Plate 2.
3. Wobbler mice
The results of FTIR in wobbler mice should be treated with
caution as many of the mice studied showed extensive changes in terminal
innervation with few axons ending in clear terminal arborizations. In
each specimen large numbers of fine 'beaded' nerve fibres were seen
'wandering' among the muscle fibres, some ending in growth cones, whilst
others were not seen to end at all. These fibres are often so numerous
that they mask any normal appearing axons. In the intramuscular nerve
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bundles a majority of the fibres appear to be very fine and unmyelinated
but even in animals at an advanced stage of the disease a few normal
myelinated fibres are still present. Some examples of 'dying-back'
may also be found as well as Wallerian degeneration. Often it is in
the older 'wrwr* mice that the terminal innervation characteristics for
lower motor neurone disease, can be most clearly seen (Co&rs and Woolfe
1959)• The innervation ratio calculated for these mice is probably a
gross underestimate of the true FTIR because few axons can be seen to
terminate in clear end-plates. Innervation of wobbler muscle is shown
in Plate 3«
b) The Dystrophic Colony
1. Phenotypically healthy animals
There appears to be no abnormality in phenotypically healthy
animals of this colony; terminal innervation does not seem to be
affected by the 'dy' gene in heterozygote mice but the number of mice
studied from this group was very small.
2. The dystrophic mice
The functional terminal innervation ratio in dystrophic mice
is slightly raised. Although a few regenerative fibres are seen they
are not a common feature; axons in the intramuscular nerve bundles
mostly appear normal but some subterminal axons do show features of
repeated demyelination and remyelination (see Plate 4). Some axon
swellings are found primarily close to terminal arborizations. The
collateral branching seen in dystrophic mice has a few similar features
to that seen in wobbler mice, but any axon ramification i3 mainly terminal
or ultraterminal innervating muscle fibres close to the original termi¬
nal end-plate. Axonal branches mostly end in small poorly developed
end-plates possibly resembling those described for human myotonic dys¬
trophy (Allen, Johnson & Woolfe 1969). There is, however, no evidence
of several end-plates being found on a single muscle fibre. It may¬
be that these small newly formed end-plates are not developing on atro¬
phic fibres but on fibres occurring as a result of muscle fibre split¬
ting, a well recognised feature of muscle degeneration in muscular dys¬
trophy in both man (Isaacs, Bradley & Henderson 1973) and animals
(Harman et al 19631 Bray & Banter 1970).
ii) End-plate Studies
a) Size
The mean end-plate sizes for the individual mice are given in
the Appendix (Appendix 5 Table l). The mean end-plate sizes for all
phenotypically healthy animals are very similar (see Fig. 5.l). There
is no correlation between end-plate size and age (r = 0.27 p^l). The
mean size of end-plates from mice with hind-limb paralysis is slightly,
though not significantly larger than normal. The mean end-plate size
is also slightly increased in dystrophic mice. Table 5*3 gives the
mean sizes for the groups of animals.
It can be seen from Table and Fig. 5*1 that only end-plates
of wobbler mice differ in size from controls (wrwr e.p. size compared
with C57/BL PC0.02). The mean size of wobbler end-plates is also signi¬
ficantly reduced when compared with phenotypically healthy animals from
the wobbler colony (wrwr e.p. compared with WrWr/Wrwr + Wrwr P<t).0l).
There are, however, individual animals with lower motor neurone disease
whose mean end-plate sizes fall within the normal range; these are the
older animals which probably manifest a more slowly progressing form of
the disease. There is no indication of large numbers of small end-
plates innervating the dystrophic muscle but there appear to be numerous
small end-plates in wobbler muscle.
b) Structure
The various types of end-plates found are illustrated in Plate
FIGURE 5.1
The distribution of man end-plate
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5 • When the phenotypically healthy groups of animals were com¬
pared with one another no statistical significance was found between
the percentages of 'simple' or 'T^' end-plates in each of these groups.
The results from all these animals were therefore pooled and a correla¬
tion analysis of the percentage of 'T ' end-plates against the age of
the mouse was carried out. There was a significant correlation between
the reduction in the number ofxT^ end-plates and the age of the mouse
(r = O.6189 P<.0.01)• The percentages of end-plates within every
classification for each of the seven groups of animals are given in
Table 5»^« Fig. 5.2 shows the distribution of the percentage T^ end-
plates within each of the groups.
1. The wobbler colony
The percentages of end-plates classified into each type do
not vary significantly between wobbler and healthy mice except in the
v #
case of the group T + C where in the wobbler the number is significantly
raised (P O.Ol)} however the number of end-plates within this category
is very small.
2. The dystrophic colony
The end-plate structure in dystrophic mouse muscle seems to
be the most prominent abnormality of innervation. The percentage of
•T ' or simple end-plates is reduced (P<0.0l). The percentage of
'T_j+ S' end-plates, those with one myelinated axon branch but also bear¬
ing a sprout, is increased (P<0.00l). The percentage of T^ end-plates
is increased (P<0.00l). The percentage ofXT,> + S'end-plates is
increased (P<0.02) as well as the percentage of T + C'end-plates
(P< 0.001) and^T^ end-plates (P<O.Ol). These comparisons are all
with C57/BL control animals. There is also an increase in the percen¬
tage of duplex end-plates but these occur very rarely, hence percentages
are very small in the order of 0 to yj>» However, only one duplex
TABLE 5.5
A statistical comparison using Student's -t test of end-plate size
and structure of each mutant group against that of the control group
Results +for the control (C57/BL| mice
Mean - SD Mean - SD Mean - SD Mean - SD Mean - SD
EP size 9b T^EP T± +C EP EP EP
30.7 - 1.1 63.6 - 9-5 27.5 - 4.9 6.8 - 4.8 0.17 - 0.4
WrWr/Wrwr NS NS NS NS NS
Wrwr NS NS NS NS NS
Wr/HLP NS P< 0.1 NS NS NS
wrwr P<0.01 NS NS NS NS
DyDy/Dydy NS NS NS NS NS
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end-plate was seen in the mice of C57/BL colony and two in healthy
animals from the dystrophy colony.
iii) Summary of results from studies of peripheral innervation
Wobbler mice have an increased functional terminal innervation
ratio with a decreased mean end-plate size. Small end-plates are con¬
sistently found in animals where the disease appears to be progressing
rapidly. Many end-plates, however, may be near normal size in older
animals where the progress of the disease appears to have slowed down.
The reduced end-plate size would probably not be significant if it were
correlated with muscle fibre size (Zacks 1964). The morphology of
wobbler end-plates appears to be normal when studied using the outlined
criteria. There may, however, have been some end-plates placed into
theNT^ category which, although innervated by only one branch of an axon,
\ /
may not have been true T end-plates, in that the axon may have been
1
unmye1inated.
The Wr/HLP mice have an increase in FTIR which is not as high as
that of wobbler mice. They show degenerative changes of the subterminal
axon, such as evidence of abnormality axons and of Wallerian degener¬
ation. The mean end-plate size is slightly but not significantly raised.
End-plate size would be of little value as an indication of disease in
these animals, as would analysis of end-plate structure, although slight
increases in the number of the more complex end-plates such as T^ and
\ '
T0 + C have been observed. These increases have also been found in
one of the two mice in the WrWr/Wrwr group suspected of being example of
the pre-clinical changes in terminal innervation which presumably would
subsequently result in hind-limb paralysis. The percentage of T end-
plates in this mouse as well as in most Wr/HLP mice is still within the
normal range, therefore is not a significant diagnostic feature.
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In dystrophic mice a slight increase in terminal innervation is
observed, but many axons show either demyelination or fusiform swellings
especially in the vicinity of the terminal arborization. The mean end-
plate size is slightly though not significantly increased. Many end-
plates appear to be undergoing degenerative changes. The number of
simpleNT^ end-plates is decreased, whereas the percentage of more com¬
plex end-plates is increased; most prominent are the relatively high
percentages ofxT' andxT + c'type end-plates.
The study of peripheral innervation in heterozygote mice of both
the wobbler and the dystrophic colony does not reveal changes in inner-
vation associated with heterozygosity. There are, however, some changes
in the pattern of innervation associated with increase in mouse age.
The FTIR increases slightly with age whilst the number of 'T ' end-plates
reduces as a result of an increase in the more complex terminal arbori¬
zations.
These studies have only been carried out using the gastrocnemius
muscle and it is not certain whether the results would apply equally to
other limb muscles.
IV. Discussion
This study on terminal innervation in mice has been rather limited
in that the number of animals studied was small. It has, however, pro¬
vided further evidence to suggest that the ageing process is reflected
in muscle by limited changes within the terminal innervation. Studies
of limb muscles in certain small mammals have led to the suggestion that
sprouting occurs under normal conditions, some of which could be accounted
for as the result of growth and degeneration due to age (Barker & IP
1965). An ageing process in human muscle has also been implied.
Beyond the age of sixty a progressive fall in the number of motor units
has been demonstrated (Campbell, McComas & Petito 1973) and so long as
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the motor unit count does not fall below twenty percent, muscle size
and strength is maintained as a result of functional compensation, thus
masking the severity of motor unit loss (Brown 1973)* Single fibre
atrophy has been reported in humans over sixty (Adams 1969) and axonal
degeneration with increased collateral ramification has also been demon¬
strated in the peroneus brevis muscle of elderly patients (Harriman,
Taverner & Woolf 1970). Collateral branching with an increased terminal
innervation ratio as a result of increase in age has not been demonstrated
by Coers and his co-workers. In their study of over thirty normal
muscles, the specimens examined were not taken from distal muscles of
the legs and the methods used for scrutinising controls in which those
with histological changes in the muscle were disregarded, would probably
account for the inconsistency in their results with those of other studies
as muscles showing ageing changes would have been discarded (Coers,
Telerman -Toppet & Gerard 1973). A comprehensive study of the effect
of ageing 011 the growth and degeneration of motor end-plates in hind-limb
muscles of the cat has revealed that two separate phenomena occur as a
consequence of ageing, a growth effect resulting in an elaboration of
the end-plate structure, and the degeneration of end-plates in response
to muscle fibre loss (Tuffery 1971)• The results of the present study
appear to confirm these observations for the gastrocnemius muscle of
the mouse. Both an increase in collateral branching and end-plate
'elaboration' has been demonstrated to correlate with the increased age
of the animals studied. There appears to have been no previous study
of age effect on innervation in mouse muscle. The results of the present
study, however, will require confirmation using a larger number of ani¬
mals, a wider age range, and various proximal and distal limb muscles.
From the observations on terminal innervation ratio and end-plate
structure no variation was detected between the results in control
62
C57/BL mice and those of heterozygotes from either the wobbler or the
dystrophic colonies. The nunfcer of animals within each group has
however been a limiting factor. Much larger numbers would be required
to consider whether the rate in the ageing process in muscles of hetero-
zygote mice of either colony would be indicative of any detrimental
effect of the heterozygote gene. There are suggestions that hetero-
zygote carriers of lower motor neurone disease in humans do show some
abnormalities in muscle (Emery, Anderson & Noronha 1973)• Innervation
in human carriers has not been studied in great detail although obser¬
vation on a single male and female carrier of SMA will be reported in
Chapter 8.
The study of functional terminal innervation ratio in the wobbler
mouse muscle has confirmed that extensive axon sprouting and collateral
innervation is a feature of the disease (Duchen, Strich & Falconer 1968).
It has, however, shown that FTIR in these mice is of little value as
an indicator of the rate of progress of the disease. In animals where
the disease is most benign one would expect a lower FTIR than in those
where the disease progresses more rapidly; this is not always true
since in those animals where the muscle is less atrophied the number
of axons is greater and hence they can be more easily and accurately
measured. The results for this aspect of the study have demonstrated
that the FTIR innervation ratio alone is not always very reliable in
estimating disease prognosis, possibly even less so where the muscle
chosen for study is believed to be only mildly affected by the disease
process.
End-plate sizes of wobbler mice are smaller than in healthy animals;
such a result would be expected if one does not correct for muscle fibre
size (Zacks 1964), and where the area of cholinesterase activity is used
as a measure of end-plate size. Muscle fibres innervated by collateral
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branches may have small underdeveloped end-plates, whilst degenerating
end-plates may have a low cholinesterase activity. More surprising
perhaps is the relatively small number of complex end-plates found in
the affected mice. It would appear that in "these animals the 'dying-
back' phenomenon is not associated with an elaboration of the terminal
arborization structure.
Innervation studies on gastrocnemius muscle from mice with hind-
limb paralysis (Wr/HLP) demonstrate clearly the involvement of a neuro¬
genic factor in the pathological process seen in these animals. The
FTIR is increased, thus indicating a form of neurogenic atrophy. An
electrophysiological study on the extensor digitorum longus muscle of
the wobbler mice displaying a hind-limb paralysis has demonstrated the
similarity between results for this muscle and those found in the proxi¬
mal fore-limb muscles of affected mice with no hind-limb paralysis
(Harris 1975)• Harris suggests that wobbler mice with the hind-limb
paralysis demonstrate an abnormal distribution of affected muscles.
The mice with late onset hind-limb paralysis which have been used in
this study would require electrophysiological investigation to enable
further clarification of the disease pathology.
The Wr/HLP mice show no differences in mean end-plate size and,
although there is a slight increase in the complexity of end-plate
structure, the abnormal terminal innervation ratios and the large num¬
bers of fine axons in the muscle are much more striking features of the
disease pathology. Electronmicroscopic studies of end-plate in these
mice may prove more revealing.
Terminal innervation studies in dystrophic mouse muscle suggest
that a neurogenic factor may be involved in the disease process. There
is mounting evidence regarding the neurogenic involvement in murine
muscular dystrophy (McComas, Sica & Currie 1970; Bradley 1971; Harris,
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Wallace & Wing 1972; Bradley & Jenkison 1973)* The dystrophic process
in mouse is nevertheless not equivalent to the neurogenic atrophy found
in wobbler mice (Harris & Ward 1974) nor to atrophy resulting from
surgical denervation (Law & Atwood 1972). The observations from the
study of terminal innervation have further confirmed that the peripheral
nerve in the dystrophic mouse does not resemble that of wobbler mice and
that the pattern of innervation differs from that found in mice with
hind-limb paralysis. The functional terminal innervation ratio is
slightly elevated but it does not represent the primary neural abnorma¬
lity in the muscle. The structure of some subterminal axons, which
show evidence of a thickening of axons I ,or fusiform
swellings, and the grossly abnormal appearance of many end-plates are
much more prominent features of the abnormalities in peripheral inner¬
vation seen in dystrophic mice.
The increase in FTIR in dystrophic mice may be due to a slight
neurogenic atrophy. The collateral sprouting of axons, however, may
be in response to fibre splitting; the axon branches innervate small
•atrophic-like' fibres which appear similar in size to those found in
neurogenic atrophy. The branching axons do not resemble those found
in atrophic conditions. Electrophysiological results from human
Duchenne type muscular dystrophy suggest that existing axons innervate
new fibres and fibres which result from longitudinal fibre splitting
rather than collateral branching occurring in response to neurogenic
atrophy (Desmedt & Borenstein 1973)•
The extent of damage to the peripheral nerve resulting from the
disease in murine muscular dystrophy is not suggestive of a purely myo¬
pathic nature of the disease, although the pathological changes in the
sub-terminal nerve are most prominent at the neuromuscular junction;
consequently it could be argued that they are the direct result of an
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impairment in the muscle. However, a myopathy stimulated by the admini¬
stration of cardiotoxin into an area of mouse muscle results in perma¬
nent changes of end-plate structure but such a myopathy does not cause
axonal damage (Duchen et al 197^). The administration of the neuro¬
muscular blocking agent, botulinum toxin, into mouse gastrocnemius has
been found to result in similar damage to peripheral nerve and muscle
as that found in murine muscular dystrophy (Duchen 1971)• This result
indicates a possible neuromuscular block or an abnormality of some
neural 'trophic' factor, resulting in pathological changes of both nerve
and muscle. The concept of a 'trophic' factor being involved in the
pathogenesis of certain neuromuscular diseases is not new. Experiments
involving the transplantation of muscle from dystrophic mice to healthy
ones and vice versa have been designed to demonstrate whether the dys¬
trophic nerve is a prerequisite of the disease (Salafsky 1971? Laird-
Ralston 1972; Neerunjun & Dubowitz 1975)• The results of these studies
are contradictory and often the limitations of transplantation experi¬
ments, such as the immune response Of the host to the inserted muscle
and even such changes as result from transplantation of muscle from one
area to another within the same animal, are not taken into account when
interpreting these results (Carlson 1970). The results from in vitro
experiments are also inconsistent (Gallup & Dubowitz 1973; Moore M.J.
1975)» therefore they have so far proved of little value. It has been
suggested that the denervation of dystrophic muscle does not result in
a cessation of the dystrophic process (Banker & Denny-Brown 1959) and
an attempt to induce impairment of a possible 'trophic' effect of the
nerve by repeated denervation and reinnervation experiments does not
result in muscle changes similar to those found in dystrophy (Bradley
1972). These experiments indicate that a neural 'trophic' effect is
not responsible for the disease process in dystrophy. On the other
hand, however, dystrophic muscle does not respond to cross reinnervation
in the same way as normal muscle (Law & Atwood 1972); an abnormality
in axoplasmic flow in murine dystrophy has been reported (Bradley &
Jaros 1973)» and altered neural proteins have also been demonstrated
(Salafsky & Sterling 1973)* Such evidence would be indicative of a
neural involvement. Also an abnormality in the ventral roots in animals
with mouse muscular dystrophy has been reported (Bradley & Jenkison 1973)•
It would be unlikely that such changes in the nerve would be dissociated
from those found in muscle. The abnormalities of peripheral nerve at
the level of the subterminal axon and terminal arborization reported in
this study may be a consequence of the changes in the nerve root. There
is, therefore, considerable evidence implicating a neural factor in the
pathogenesis of murine muscular dystrophy. The disease, however, may
be the result of a more generalised metabolic condition manifesting
itself in both muscle and nerve (Emery & Gosdon 197^)» The results of
this study, although they have outlined the morphological features
involved in the degeneration of the subterminal axon in murine dystrophy,
do not resolve the present confusion regarding the importance of the
nerve in the dystrophic process.
A further observation made on the preparations of dystrophic muscle
may be of some value. The considerable interest in the pathogenesis
of murine muscular dystrophy has resulted from the resemblance of this
disease, primarily in muscle histology, to that observed in human dys¬
trophies. Evidence;of a neural involvement in human dystrophy is not
very substantial (Emery & Gosdon 197't). The original suggestion of
denervation in Duchenne type muscular dystrophy based on electrophysio¬
logical results (McComas, Sica & Currie 1971) is now being questioned
(Scarpalezos & Panayiotopoulos 1973)- It is therefore surprising that
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some features described for innervation changes in Duchenne muscular
dystrophy (Jedrzejowska, Johnson & Woolf 1965) resemble those noted in
this study for murine muscular dystrophy. Although comparisons between
species, especially where a disease process is involved, are not entirely
justified, it is however possible that the disease in man and mouse have
a common origin. It seems possible that in both mouse and man the
variable manifestations in nerve and muscle result from a more general¬
ised, metabolic abnormality (Rifenberick, Gamble & Max 19735 Montalbo
& Kabara 197^5 fimery & Gosdon 197^)•
PLATE 1
a) Normal innervation in the gastrocnemius muscle from
a wobbler littermate (VrWr/Wrwr). Age 2 months.
Ache/Silver impregnation x 400
•
b) Normal innervation in gastrocnemius muscle from a wobbler
littermate (WrWr/Wrwr). Age 4 months.
Ache/Silver impregnation x 400
c) Normal innervation in gastrocnemius muscle from a
C57/BL mouse. Age 4 months.
Ache/Silver impregnation x 160
d) An intramuscular nerve bundle in the gastrocnemius muscle
from a wobbler littermate (WrWr/Wrwr,). Age 4 months.






a) Innervation in the gastrocnemius muscle of a Wr/HLP. mouse.
Age 6 months
Ache/Silver impregnation x 4,00
b) Innervation in the gastrocnemius muscle of a Wr/HLP mouse
Age 7 months
Ache/Silver impregnation x 160
c) Axonal branching in the gastrocnemius muscle of a Wr/HLP mouse.
Age 6 months.
Ache/Silver impregnation x '<»a
PLATE 2
PLATE 3
a) Innervation in the gastrocnemius muscle of a wobbler (wrwr)
mouse. Age 2 months
Ache/Silver impregnation x 400
b) Innervation in the gastrocnemius muscle of a wobbler (wrwr)
mouse. Age 5 months
Ache/Silver impregnation x 400
Axonal branching and "beaded" axons are visible
c) An intramuscular nerve bundle in the gastrocnemius muscle
of the wobbler (wrwr) mouse. Age 5 months
Ache/Silver impregnation x 400
Demyelinated axons and a loss of axons can bo seen.
PLATE 3
PLATE 4
a) Innervation in the gastrocnemius muscle of a dystrophic (dydy)
mouse. Age 3 months
Ache/Silver impregnation x 400
Axonal branching can be seen
b) Innervation in the gastrocnemius muscle of a dystrophic (dydy)
mouse. Age 3i months
Ache/Silver impregnation x 400
Axonal branching can be seen
»'
c) Innervation in the gastrocnemius muscle of a dystrophic (dydy)
mouse. Age 3 months
Ache/Silver impregnation x 400
Sprouting from the end-plate can be seen
PLATE k
PLATE 5
a) An end-plate innervated by two myelinated branches from a
single axon ( 'Tg' end-plate) from the gastrocnemius muscle
of a C57/BL mouse
Ache/Silver impregnation x 625
The T end-plate is indicated by a single arrow.
C*
A branching axon is indicated by a double arrow.
b) A 'Tn' and possibly also a 'T ' end-plate from the gastrocnemius
muscle of a wobbler heterozygote (Wrwr) mouse
Ache/Silver impregnation x 625
The 'T • end-plate is indicated by a single arrow
The 'T ' end-plate is indicated by a double arrow
c) Multiple myelinated branches to a single end-plate in the
gastrocnemius muscle of a Wr/HLP mouse
Age 7 months
Ache/Silver impregnation x 625
d) A grossly abnormal end-plate, from the gastrocnemius muscle
of a dystrophic (dydy) mice. Age 3i months
Ache/Silver impregnation x 525»
PLATE 5
CHAPTER 6
HISTOLOGICAL AND HISTOCHEMICAL STUDIES
OF MUSCLE
I. Introduction













6.1 The Animals used in the study
6.2 Results of Histological Studies




In laboratory investigations of neuromuscular disease, histological
and histocheraical examinations of skeletal muscle specimens are of
primary importance fengel 19&2). Histological observations are of
value in determining gross pathological changes in muscle such as
fibre atrophy, scattered or grouped, hyalin or vacuolar degeneration,
phagocytosis, fibre necrosis, fibre splitting etc. Measurements of
muscle fibre diameter may be of further value in determining whether
fibre atrophy or hypertrophy can be regarded as a significant feature
of the disease. Pathological changes in muscle vary in different
diseases, but there are certain characteristics which distinguish myo¬
pathies from neurogenic atrophies (Dubowitz & Brooke 1973)*
Histological studies alone often yield insufficient information
to command an accurate diagnosis of a particular disease and additional
histocheraical studies may be required. The particular enzymatic
activity of individual muscle fibres determines their type. There
have been suggestions that there may be as many as eight different
fibre types in mammalian skeletal muscle (Roraanul 1964). Brooke and
Kaiser (1970) however, studying the enzyme myosin ATPase, have shown
that at a pH of 9»^ two main fibre types can be distinguished in both
human and animal muscle. Fibres of low activity at this pH are
denoted as Type I fibres, the remaining as Type II. The type II fibres
can be further subdivided in three subsections according to the pH
range at which the myosin ATPase remains active. There is experimen¬
tal evidence to suggest that muscle fibre type is determined by the
motor neurone and that fibres of a single motor unit are of one type
(Brooke, Williamson & Kaiser 197l)« There appearsto be agreement now
that there are three important fibre type groups, Type I, Type IIA and
Type IIB. In the study of human muscle, the classification of fibres
into the two main fibre types has been suggested as being sufficient.
Animal muscle requires typing into three fibre types because of the
much larger proportion of intermediate fibres.
It is now well established that a feature of muscle pathology
resulting from peripheral nerve damage is the altered spatial distri¬
bution of muscle fibre types. In experimental reinnervation the
mosaie pattern which is the normal feature of muscle, becomes altered,
the amount of grouping varying from a few fibres in one group to a
large number of fibres within others. Experimental denervation
and reinnervation has been found to lead to the motor unit being
enclosed within a smaller area although involving the same number of
fibres (Kugelberg, Edstrom & Abbruzzese 1970). In lower motor neurone
disease fibre type grouping occurs as a result of collateral branching
with the motor unit size becoming increased. Alteration of the histo-
chemical profile of muscle may occur as a result of disease (Johnson
et al 1973) or in connection with the ageing process of the muscle
(Jennekens, Tomlinson & Walton 1971)*
In this study only mouse muscle has been used. Histological
studies on mouse muscle have largely been concerned with examining
diseased muscle such as is found in murine muscular dystrophy (West &
Murphy i960, Pearce & Walton 1963, Goldspink & Howe 1968). Although
histochemical studies of normal muscle are numerous, few have concen¬
trated on normal mouse muscle. In mouse diaphragm muscle fibres
have been shown to be predominantly of the type II variety when classi¬
fied using myosin ATPase; however, all fibres are high in oxidative
enzymes (Davies & Gunn 1972). Although this is not entirely true for
skeletal muscle in general, many muscles are made up of largely one
fibre type. Such a pattern inevitably creates problems when investi¬
gating possible changes of fibre type distribution as a result of
disease.
70
The purpose of this study has been to establish the extent to
which changes in the subterminal nerve of Wr/HLP mice (see Chapter 5)
are reflected in altered muscle pathology and to compare these find¬
ings with the histological and histochemical profiles observed in
wobbler mice.
II. Material and Methods
i
i) Material
The study is largely based on investigations of the gastrocnemius
from control mice (C57/BL) and mice of the wobbler colony. The num¬
ber of mice in each group is given in Table 6.1.
ii) Methods
Mouse muscle was removed from the animal and prepared for section¬
ing as detailed in Chapter 2. Transverse sections of 10 thickness
were cut using the retracting microtome. An attempt was made only
to use sections from near the centre of the muscle and not from the
tendon regions.
a) Staining techniques
Each specimen was stained with the histological stains
haematoxylin/eosin and Gomori-trichrome. The histochemical procedures
used were NADH-diaphorase activity and myosin ATPase activity at pH 9»4
and 4*3 (for details of staining procedures used,see Chapter 2).
b) Observation of tissue
1. Histology
Each muscle specimen was examined for evidence of necrosis,
phagocytic infiltration and the existence of granular fibres. The
percentage of fibres showing central nuclei was obtained by counting
500 fibres at random. The diameter of 200 fibres was measured for
each sample. Measurements were made directly from the slides to the
nearest 2.5JJ using 400 x magnification.
TABLE 6.1 - THE ANIMALS USED IN THE STUDY
Genotype No. studied Age rangein days
C57/BL 6 80 - 160
WrWr/Wrwr 3 54 - 124
Wrwr 3 237 - 300
Wr/HLP 5 182 - 266
wrwr 3 98 - 136
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2. Histochemistry




The results of the histological studies are given in Tables 6.2
and 6.3# The mean fibre diameters for all mice, except the wobbler
affected animals were found to be remarkably similar. However, there
was a correlation between fibre size and age in the C57/BL mice
r = 0.79 P< 0.05. In the Wr/HLP mice the correlation, though not
statistically significant, reflects a decrease in fibre size with age
r = -0.72 P> 0.1. These results are indicative of an increasing
number of small atrophic fibres as the disease progresses.
The coefficient of variation of fibre size in wobbler mice is
much higher than in healthy mice. There is no overlap of results
between these two groups (see Figure 6.1). The mean coefficient of
variation for the Wr/HLP mice is greater than for the control animals.
Although there is no overlap of results between Wr/HLP and C57/BL mice,
the control animals are considerably younger; there is, however, some
overlap with the heterozygotes which are more closely age-matched.
Muscle from Wr/HLP mice does show a greater number of necrotic
foci than are seen in healthy animals. Granular fibres and fibres
with central nuclei were found to be uncommon in both healthy and
Wr/HLP mice; central nuclei are a feature of wobbler mouse muscle,
although these occur mainly in the atrophic fibres, whereas few are
visible in the more normal appearing areas of the muscle. Muscle
histology is illustrated in Plate I.
ii) Histochemistry
The histochemical investigations did not prove very successful
TABLE 6.2 - RESULTS OF HISTOLOGICAL STUDIES
Fibre Size Significant . . Significant
Genotype (u) difference difference
Mean SD from controls v*"ationl*J from normal
C57/BL 45.6 3.0 - 21.5 -
WrWr/Wrwr 43.5 2.0 NS 22.4 NS
Wrwr 50.3 4.5 NS 23.2 NS
Wr/HLP 43.8 3.5 NS 30.6 P<0.001
wrwr 29.5 5.4 P< 0.001 43-9 P <0.001







1 2 3 4 5
Age in days 80 90 90 106 120
Mean fibre size(ju) 43.67 45.63 45.46 46.55 41.35
SD 8.7 9.8 9.7 11.6 8.9
Coeff. variation 19.9 21.5 21.3 24.9 21.5
Age in days 54 74 124
Mean fibre size(ju) 40.82 45.59 44.01
SD 9.5 11.3 8.5
Coeff. variation 23.3 24.8 19.3
Age in days 237 266 300
Mean fibre sixe(jm) 43.97 54.50 52.47
SD 11.7 13.0 11.3
Coeff. variation 26.6 23.8 19.3
Age in days 182 188 203 266 ?
Mean fibre size(^i) 45.98 49.64 42.36 41.43 39.76
SD 16.3 15.3 12.4 13.6 15.7
Coeff. variation 35.4 30.6 29.2 32.8 25.I
Age in days 98 111 136
Mean fibre size(jj) 25.76 25.60 37.20
SD 12.3 13.6 11.5






The range of coefficients of variation
of muscle fibre size in the five groups of mice studied
FIGURE 6.1
C57/BL WrWr/Wrwr Wrwr wrwr Wr/HLP
because the gastrocnemius muscle is primarily composed of one fibre
type. Only the deep-head of the muscle is composed of mixed fibres.
Although fibre-type grouping can be readily seen in the wobbler mouse,
no similar feature could be distinguished for the Wr/HLP mouse.
Histochemical profiles of muscle in wobbler and Wr/HLP mice are illus¬
trated in Plates 2 and 3*
IV. Discussion
The wobbler mice used in these investigations were all free from
paralysis of the hind-4.imbs, however both muscle atrophy and ifibre-type
grouping are clearly visible. These features which are in agreement
with those expected for a spinal muscular atrophy are not prominent
in the Wr/HLP mice, even though these animals show a paralysis of the
hind-limbs. The features of muscle histology and histochemistry of
mice with late onset hind limb paralysis resemble in many ways those
suggested for myopathic conditions (Dubowitz & Brooke 1973)• Muscle
fibre sizes, although showing an increased variance, do not appear as
two distinct peaks, the normal fibres and the atrophic fibres, but
there appears to be a wider spectrum of fibre sizes. There is also
no overlap in coefficients of variation for muscle fibre size between
wobbler and Wr/HLP mice. The coefficient of variation is probably
the most useful measure of abnormality in muscle as it has been shown
to be largely independent of age and sex effects, and the muscle or
area of muscle used (Lumb, Vassilopoulos & Emery 1976). Observations
of histological and histochemical preparations of muscle from patients
with diabetic neuropathy have led to the suggestion that changes cus¬
tomarily attributed to myopathies may also occur in chronic neuropathic
conditions (Vassilopoulos - personal communication). An important
histological characteristic of myopathic degeneration is the migration
of nuclei into the centre of the fibre; Wr/HLP mice show very few
73
fibres with central nuclei. The histological changes seen in Wr/HLP
muscle may therefore be compatible with a chronic neurogenic condition.
The results of histochemical studies of Wr/HLP gastocnemius muscle
do not indicate any fibre type grouping. These observations are sur¬
prising when one considers that the FTIR in these animals is raised.
It has, however, been demonstrated in human muscle that collateral
branching may be well developed and yet no fibre type grouping is
seen with NADH-diaphorase (Morris & Raybould 1971)• In fact a branch¬
ing axon has been shown to innervate two muscle fibres with different
NADH-diaphorase activity (Morris & Woolf 1970). Cross reinnervation
experiments have shown that very few fibres convert from one type to
another, hence such results have questioned the importance of the
nerve in muscle protein synthesis (Samaha, Guth & Albers 1970).
Therefore, there may be no inconsistency with the results for
terminal innervation studies and the histochemical profile in Wr/HLP
mice. Furthermore it has been demonstrated that after nerve crush¬
ing, although collateral branching can be observed, no histochemical
modification can be distinguished for at least twenty-eight days after
injury and evidence of fibre-type grouping does not occur until about
the forty-second day (Warszawski ^ 1975)* It is possible that in
a slow progressing neuropathy, such as is seen in mice with the late
onset neuromuscular disease, the changes in the histochemical profile
of the muscle are minor and occur relatively slowly. Although it
also appears likely that the gastrocnemius muscle in Wr/HLP diseased
mice is relatively mildly affected compared to other muscles of the
hind-limb and pelvic musculature. The changes visible in the gastroc¬
nemius muscle do not explain the paralysis seen in these mice, parti¬
cularly as in the wobbler mouse where the muscle appears to be more
seriously affected, the hind-limbs maintain considerable mobility.
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A much more detailed histological and histochemical examination of all
hind-limb muscles from Wr/HLP mice would be necessary in order to dis¬
tinguish the muscle primarily affected by the disorder* The present
data does not disprove the hypothesis that paralysis in the Wr/HLP
mouse is the result of an abnormal manifestation of the 'wr' gene.
Nevertheless if all hind limb muscles in these mice appeared mildly
affected as compared to the wobbler, the extent of paralysis in Wr/HLP
mice would be difficult to explain in terms of a spinal muscular
atrophy.
PLATE 1
a) A transverse section of Qastrocnemius muscle from a wobbler
littermate (WrWr/Wrwr). Age 3 months
Haematoxylin/Eosin x 160
b) A transverse section of gastrocnemius muscle from a wobbler
(wrwr) mouse. Age 4 months
Haematoxylin/Eosin x 160
c) A transverse section of gastrocnemius muscle from a dystrophic
(dydy) mouse. Age 3 months
Haematoxyiin/Eosin x 160
d) and e) Transverse sections of gastrocnemius muscle from a
Wr/HLP mouse. Age 5 months
Haematoxylin/Eosin x 160
Some foci of atrophic fibres and some possible "wedged"
fibres can be seen
Atrophic foci indicated by a single arrow
Possible "wedged" fibres indicated by a double arrow.
PLATE
PLATE 2
a) Transverse section of gastrocnemius muscle from a wobbler
(wrwr) mouse. Age 3 months
Myosin ATPase pH 4.3 x 63
b) Transverse section of gastrocnemius muscle from a wobbler
(wrwr) mouse. Age 3 months
Myosin ATPase pH 9*4 x 63
c) Transverse section of gastrocnemius muscle from a wobbler y
(wrwr) mouse. Age 3^ months
Myosin ATPase pH 4.3 x 160
Fibre type grouping is clearly visible
i
r Y
d) Transverse section of gastrocnemius muscle from a Wr/HLP
mouse. Age 5 months
Myosin ATPase pH 4.3 x 160




a) Transversa section of gastrocnemius muscle from a wobbler
littermate (WrWr/Wrwr)• Age 3 months
NADH - diaphorase x 63
b) Transverse section of gastrocnemius muscle from a wobbler
(wrwr) mouse. Age 3 months
NADH - diaphorase x 160
•i
c) Transverse section of gastrocnemius muscle from a Wr/HLP
mouse. Age 5 months
NADH - diaphorase x 160
PLATE 3
CHAPTER 7
HISTOLOGICAL STUDIES ON THE SPINAL CORD
I. Introduction








The pathological changes in anterior horn cells of wobbler mice
have been studied using both light and electronmicroscopic techniques.
Duchen (1968) reported that in early stages of anterior horn cell
degeneration the nerve cell enlarges, occasionally becoming rounded.
The Kiss I substance of the perikaryon stains poorly whilst the nucleus
with its prominent nucleolus remains in the central position as in
normal cells. As degeneration progresses the cell body becomes filled
with vacuoles and in some cells the nucleus loses its central position.
In the final stages of degeneration the nerve cell is barely recognis¬
able, the nucleus being surrounded by an ill-defined mass of vacuoles.
Andrews & Maxwell (1969) confirmed these findings and studied the fine
structure of degenerating motor neurones. They suggested that the
vacuoles seen in the electronmicroscope were of two kinds. The first
type resulted from an enlargement of Golgi cisternae, which were
usually to be found in a perinuclear location; other organelles in
such affected cells remained normal. The second type of vacuole found
to be generally distributed throughout the perikaryon appeared to be
located in neurones with no identifiable ?olgi complex and were found
to be focal cystic expansions of other membrane systems, predominantly
the endoplasmic reticulum. These vacuoles did not appear to take up
any of the commonly used histological and histocheraical stains.
Further studies regarding degenerating neurones in spinal cord of
wobbler mice have shown that in affected animals the number of neurones
becomes reduced by between 13-71%» The loss of motor neurones appears
to be greater in the cervical cord than in the lumbar and lumbosacral
cord, particularly in the early stages of the disease (Papapetropoulos
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& Bradley 1972). More detailed electronmicroscopic studies have
suggested a wider distribution of abnormality in the central nervous
system of these mice (Campbell 1972)* A study of both neuronal ultra-
structure and axoplasmic flow, in which intraneuronal aggregates of
tubular element? were found as well as impaired axoplasmic flow (Bird
et al 1971)1 led to the suggestion that an abnormal neurotubular pro¬
tein was involved in the disease process.
A more recent study of the cervical spinal cord and ventral roots
of wobbler mice has been carried out on a wider spectrum of affected
animals (Andrews 1975)• This study confirms that cytomembrane vacuo-
larization is the most readily detectable abnormality in the neurones
of affected wobbler mice. However, further abnormal changes are also
detectable such as non-vacuolar dissolution of the granular endoplasmic
reticulum, proliferation of cytoplasmic microtubules and neurofilaments,
lipid accumulation as well as increased numbers of lysosomes and auto¬
phagic vacuoles. Occasionally these abnormalities have been found to
occur together, although more frequently one or more of these features
becomes the prominent pathological abnormality in any one cell. The
control mice used in Andrews' study, which were genetically undefined
littermates of wobbler mice, did show some degenerative changes, such
as dilation of the colgi complex and of the granular endoplasmic reti¬
culum, some rare phagocytic cells and scattered Wallerian degeneration.
These changes were however more common in older mice and the frequency
never approached that encountered in wobbler mice.
The feature which makes the degenerative changes observed in the
wobbler mouse peculiar to it, is not that these changes occur uniquely
in this mutant but rather it is the relative frequency and distribution
with which they occur and the near absence of other changes which would
normally occur simultaneously in other neurological abnormalities
(Lieberman 1971» Raisman & Matthews 1972).
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A lower motor neurone disease in mice associated with a type C
RnV virus infection has also been reported (Gardner et al 1973)• The
most striking neuropathological changes in these diseased mice have
been observed in the lumbosacral spinal cord. Vacuoles have been
found in both grey and white matter, also a varying degree of vacuolari-
zation was seen in the neurones. Other changes included mild to
severe gliosis found primarily in,and adjacent to,anterior horn cells
and the presence of mononuclear cells of uncertain origin with swollen
cytoplasm. Neuronal vacuoles which develop in C%A infected mice
appear as multifocal dilations of the rough and smooth endoplasmic
reticulum. Some loss of motor neurones from the ventral horn of
severely affected mice has also been suggested (Andrews & Gardner 197^)•
Although the pathological features in the spinal cord of wobbler
mice and CRNA infected mice are not the same, there is a degree of
<
similarity between vacuolated neurones in these two groups of mice
(Andrews et al 1974). The clinical manifestations seen in the Wt/HLP
mouse were described in Chapter 3 and to some degree appear to be
similar to those resulting from the viral induced neurogenic atrophy.
The study of innervation and muscle histology of Wr/HLP mice are indi¬
cative of a slowly progressing neurogenic atrophy. In order to estab¬
lish the nature of the disease it is necessary to demonstrate degenera¬
tion of anterior horn cells. It is unlikely that a light microscopy
study of the spinal cord alone could verify whether the disease more
closely resembled that seen in wobbler mice or in the CRftA infected
mice; however it could be use-fi.l in the further understanding of the
late onset hind-limb paralysis of the Wr/HLP mice.
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II* Material and Methods
i) Material
The lumbar and cervical enlargements of spinal cords from a
total of twenty mice were examined: C57/BL (5)» WrWr/Wrwr (6),
Wr/HLP (3) and wrwr (6).
ii) Methods
Spinal cords were frozen and mounted for transverse sectioning.
When previously stored frozen material was being prepared for section¬
ing, extra care was taken to prevent the defrosting of the tissue
during the process of mounting. Sections of 20 ju thickness were cut
and the tissue stained with toluidine blue and the combined luxol fast
blue/cresyl violet stain (for methods see Chapter 2). The preparations
were examined for evidence of anterior horn cell degeneration and for
the presence of other visible abnormalities.
III. Results
Two preliminary observations made with regard to the gross appear¬
ance of the spinal cord were firstly that the diameter of both the lumbar
and cervical enlargements of wobbler mouse appeared to be considerably
smaller than that of other mice examined. Secondly that the cords of
both wobbler and Wr/HLP appeared to be firmer in texture and easier to
handle. The small diameter of the wobbler cord is not surprising as
the mouse is invariably smaller than an age matched littermate. The
firmer texture of the cord and the fact that it appeared less suscep¬
tible to freezing artefact may reflect an increase in fibrous tissue
as a result of anterior hern ee'l loss.
At low magnification fewer anterior horn cells were seen in the
cervical cord in wobbler mice than in controls. A loss of motor
neurones could not be seen at this magnification in Wr/HLP mice. In
the lumbar cord, at a magnification of x 63 an actual reduction in
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number of cells could not easily be seen in either wobbler mice or
Wr/HLP mice. See Plate 1.
Observations on cords from wobbler mice at magnifications of
between x 125 and x 625 demonstrate neurones in various stages of
degeneration. The most easily recognisable factor was the increased
size of motor neurones. Although the presence of vacuoles in some
neurones was seen, the tissue appeared to be very susceptible to freez¬
ing artefact thus making interpretation difficult. Some neurones
which have distinguishable nucleus and nucleolus appear to have little
nissel substance surrounding them, suggesting that these cells are in
a late stage of degeneration. Anterior horn cells in various stages
of degeneration have been found in both cervical and lumbar cord of
wobbler mice. See Plate i.
The study of spinal cords of the Wr/HLP mice has proved difficult
because of the problems of distinguishing anterior horn cell degenera¬
tion from damage caused by freezing. The cervical cord of all affected
mice closely resembled those of controls, except for the possibly
increased size of some neurones. In the lumbar cord, however, the
presence of some exceptionally enlarged neurones was the most easily
recognisable feature. As in the case of wobbler mice a number of
neurones with very sparsely staining Hiss :. . substance could be seen.
A number of cells appeared to have nuclei that were not centrally
placed and some possibly degenerate neurones were also visible.
Features of the Wr/HLP cord are shown in Plate 2 . The number of
possibly degenerating or degenerate anterior horn cells in any one sec¬
tion of the wr/HLP mouse was much less than in wobbler, but the actual
loss of cells in diseased animals was not quantified.
It would therefore appear from the results of the present study
that there is motor neurone degeneration in the spinal cord of wr/HLP
80
mice, particularly in the lumbar region of the cord as would be
expected from the clinical distribution of weakness. However,
further investigations on the spinal cord should be carried out not
on fresh frozen material but using paraffin embedded tissue.
IV. Discussion
The results of the present investigation of the histological
features of the spinal cord of Wr/HLP mice act as further evidence for
the neurogenic origin of paralysis in this disease. They have,
however, not been of value for determining whether the degeneration
seen in the cord is sufficiently similar to that found in wobbler mice
to act as evidence for the hypothesis (discussed in Chapter 3) that
the hind-limb paralysis is the result of manifestations in the hetero-
zygote of the mutant 'wr' gene. A detailed electronmicroscopic study
would be necessary. However, even such a study may not be entirely
satisfactory as varying degrees of dilation of endoplasmic reticulum
have been reported to accompany processes as varied as ageing (Andrews
1975) and exposure to toxins (Yates & Yates 1972) as well as the trans-
mi table agent such as the CRWA virus (Gardner et al 1973)# It would,
however, indicate whether an infectious particle such as the CRN\ virus
could be seen in the tissues of the central nervous system (Andrews &
Gardner 1974). If such a particle were not found and attempts at
transmitting the disease from affected animals to healthy ones by inno-
culation of homogenates of diseased nervous tissue were not successful
(Andrews et_ cQ 1974), this would be suggestive that in fact a genetic
factor was involved.
Ultimate proof that the 'wr' mutant gene is a prerequisite for
the hind-limb paralysis could only come from detailed genetic studies.
However because of the age of onset of the disease and the sporadic
nature in which it occurs, such experiments could prove difficult.
8l
If, however, ultrastructural studies were carried out on large numbers
of wobbler mice, Wr/HLP mice and known heterozygotes showing no hind-
limb paralysis, and if a spectrum of similar degenerative patterns was
demonstrated in spinal cord, this would be very suggestive that Wr/HLP
mice are manifesting heterozygotes.
The results of this preliminary study, although partially con¬
firming that muscle weakness occurring in Wr/HLP mice could be the
result of anterior horn cell degeneration, further evidence is required
to establish whether the disease in the Wr/HLP mouse has a similar
origin as that seen in wobbler mice.
PLATE 1
a) Transverse section of lumbar spinal cord from a wobbler
littermate (WrWr/Wrwr). ^Age 3 months.
•\ Stained with luxol fast blue/cresyl violet x 63
%
\
b> Transverse section of lumbar spinal cord from a wobbler
littermate. Age 3 months.
LFB/CV x 400
c) Transverse section of lumbar spinal cord from a wobbler
littermate. Age 3 months.
LFB/CV x 625
The anterior horn cells show no degenerative changes at
this magnification
d) Transverse sefction of wobbler (wrwr) cervical spinal cord.
Age 3 months.
Toluidine blue x 63
te'
e) Transverse section of wobbler cervical spinal cord. ,
Age 3 months.
T.B. x 625







a) T.S. section of lumbar spinal cord from a Vr/HLP mouse
Age 7 months
Toluidine blue stain x 63
b) T.S. section of cervical spinal cord from a Wr/HLP mouse
Age 7 months
Toluidine blue stain x 160
No degenerative changes in the anterior horn cells can
bv seen at this magnification
c) T.S. section lumbar spinal cord from Wr/HLP mouse
Age 7 months
T.B. stain x 625
There appears to be some vacuoles in the nissel substance
in the anterior horn cells
d) T.S. section lumbar spinal cord from a Wr/HLP mouse
Age 7 months
T.B. stain x 625
A grossly enlarged anterior horn cell can be seen.
PLATE 2
CHAPTER 8
STUDIES ON TERMINAL INNERVATION IN HUMAN
I. Introduction







The Patients used in Terminal Innervation Studies




Most terminal innervation studies involving human material have
utilised the vital staining technique developed by Coers (1952). This
method has one major disadvantage in that it requires very fresh tissue.
It would be of great advantage for the study of peripheral innervation
for a staining method to be equally successful on fresh tissue from
biopsy and on post-mortem material. An acetylcholinesterase/silver
technique was developed in this department for use on human foetal
material which can be used on either fresh tissue or on material several
days after death (Toop 1974)• This technique did not prove very success¬
ful on adult tissue. However a similar technique to the one used in
the study of mouse terminal innervation (see Chapter 5) has, with some
modifications, been used successfully on both fresh and post-mortem
human muscle tissue.
This technique could prove very valuable in further studies on
terminal innervation in neuromuscular disease. Its advantage over the
vital staining methods is that it allows terminal innervation to
be studied in a variety of muscles obtained at autopsy from a single
individual. Hence the effect of age in different muscles could be
assessed. There is evidence to suggest that some muscles undergo
changes in peripheral innervation more readily than others (Harriman,
Taverner & Woolf 1970). It would therefore be possible to establish a
normal range of Functional Terminal Innervation Ratios (FTIR) for
various muscles and perhaps also for different age groups. This would
be particularly useful in the study of benign forms of motor-neurone
disease and in establishing, along with electrophysiological studies,
possible neurogenic involvement in diseases believed to be primary myo¬
pathies (Stalborg, Trontelj & Janko 1970» Takahashi, Nakamura &
Nakashima 1974).
A method which can utilise post-mortem material has, in fact, many
possibilities for the study of human innervation. A high affinity of
the post-synaptic membrane for divalent metal cations has been demon¬
strated (Nakamura, Namba & Grob 1967)5 various abnormalities are
associated with poisoning by metals, especially lead. Post-mortem
studies on all patients exposed for some time to high levels of lead
would prove very useful. It would also be of great value for the
understanding of the dynamic nature of the peripheral innervation in
humans, to examine the effects on innervation of tetanus intoxication
(Duchen 1973)1 of strychnine poisoning (Doller, Crawford & Conner 1973)
and of long-term use of certain drugs especially those administered in
neurological conditions (Tallen 1962). These studies could be more
ethically carried out on post-mortem material.
The results given in this study indicate the success of the
acetylcholinesterase/silver technique for the study of human innervation
II. Material and Methods
i) Material
Human specimens were obtained from two sources. Some muscle speci
mens were acquired at post-mortem, some at biopsy operations,
where muscle was taken, for routine histology for diagnostic purposes.
Post-mortem muscle was always taken from the deltoid muscle, whilst
fresh tissue was taken either from the deltoid or the quadricep muscle,
depending on the disease of the patient being studied. Four out of a
total of seven muscle samples prepared for terminal innervation studies
proved suitable for FTIR estimations, whilst the remaining three could
only be photographed. Although numerous other specimens were obtained
they were found to have been of muscle outside the motor point area.
The details of each specimen to be reported in this study are given in
Table 8.1.

























As soon as the muscle specimen was received it was prepared for
sectioning (see Chapter 2).
A few muscle sections of 2D fx thickness were tested for cholines-
terase activity (for method see Appendix). Specimens where the pre¬
sence of end-plates was demonstrated by this method were then sectioned
for innervation studies. Muscle slices of between 50-100 fx were cut
using the retracting microtome (Slee Co Ltd). Sections of 50 fx thick¬
ness were mounted directly on to slides and dried in a current of cold
air. Tissue slices of 75-100 fi were placed as floating sections into
forraol-calcium fixative at 4°C for two hours. They were then carefully
transferred into distilled water and mounted on to clean slides.
After removing all the excess water the slides were dried very slowly.
It was essential that the slides were very clean and that drying was
allowed to proceed slowly as pre-fixed tissue is not easily mounted,
whilst the practice of coating slides with albumen to facilitate mount¬
ing resulted in poorer staining of the material. The method for the
Ache/silver stain is given in the Appendix.
The specimens where no end-plates were demonstrated by the initial
acetylcholinesterase method were not discarded immediately. They were
sectioned in the same way, but every ten sections a 20 fx section was
cut and tested for cholinesterase activity. Only when it was clear
that the entire specimen was of no value for innervation studies was
it discarded. Such a precaution was particularly necessary when the
tissue had been obtainec from a biopsy operation and FTIR studies were
important for diagnostic purposes.
The slides were examined and the FTIR estimated by the same method
as for mice (see Chapter 5), with one minor adjustment - that in human
tissue only axons greater than 150 fx in length were used in calculating
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the final result. Two estimates of the FTIR were calculated for each
specimen, one using all the available axons, a second using only axons
over 200 ju in length. It has been suggested that the probability of
subterminal branching occurring at a distance greater than 200 is
less than 5% (Co&rs, Telerman-Toppet & Gerard 1973)*
Those specimens where the area of innervated muscle was too small
to calculate the TIR were examined microscopically and a photographic
record was made of any upusual appearance in the innervation.
III. Results
The results of the FTIR for each of the specimens studied are
given in Table 8.2. The highest innervation ratio was found in a
patient with a suspected benign form of lower motor neurone disease
and, even though results of histological and histocheroical examination
of this tissue did not prove to be very satisfactory, the innervation
results suggest that the muscle weakness reported in this patient was
of neurogenic rather than myopathic origin. Plate 1 indicates col¬
lateral branching seen in this patient.
Although terminal innervation was studied in two heterozygotes of
Werdnig-Hoffraann type spinal muscular atrophy, the FTIR could not be
obtained. However some unusual features of innervation were found
(Plate 2 ). The significance of such abnormal features of innervation
cannot be clarified until more is known about the ageing phenomenon in
muscle. This has been discussed in connection with mouse muscle (see
Chapter 5)«
Only one specimen from patients with diabetic amyotrophy could be
used for assessing FTIR although a second one was stained and will be
commented on below. There is obvious collateral branching in the speci¬
men analysed, with a high innervation ratio. There are differences in
the type of collateral ramification observed as a result of lower motor
TABLE 8.2
The Results of Terminal Innervation Studies in Humans
The results of functional terminal innervation ratio for healthy
individuals (Coers, Telerman-Toppet & Gerard 1973). The normal
values are 1.11 - 0.05 (Mean ± SD), ie. the normal 95% confidence
limits are 1.01 to 1.21.
Patient No. of axons FTIR No. of axons FTIR
No. 150 p 200 ju
1 68 1.30 28 1.45
4 62 1.23 28 1.35
6 105 1.18 65 1.23
7 53 1.23 32 1.30
neurone disease and that found in this specimen. In the diabetic
patient branching was primarily pre-terminal or terminal (see Plate 3)
whilst in the case of the spinal muscular atrophy patient and the two
post-mortem biopsies to be discussed later most collateral branching
was nodal.
The second diabetic patient did show cholinesterase activity but
no terminal innervation was found; the muscle was also of no value
for histochemical or histological study. The cause of the considerable
muscle degeneration in this specimen is not clear. However, cholines¬
terase activity is known to remain for several weeks after effective
denervation (Brzin & Zajicek 1958).
Two post-mortem specimens of muscle are reported in this study.
Histochemical examination of both specimens demonstrated an obvious
Type II fibre atrophy. A slightly elevated TIR could be demonstrated
in both specimens. In patient 6, however, the innervation ratio is
not elevated much above the normal range but there is an unusually
large number of duplex end-plates (see Plate 3 ). In the case of
patient 7t who died of heart failure, the terminal innervation was
definitely raised above the accepted normal range. The patient,
however, also had a history of psychosis, and an association between
psychosis and collateral branching has been reported (Meltzer & Crayton
1974).
Histochemical studies would normally have ruled out the above-
mentioned two specimens as being inappropriate for controls in any
study of innervation; however- tiiey have been used primarily to demon¬
strate the use of the same Ache/silver method for both fresh biopsy




The results of this study confirm that the acetylcholinesterase/
silver technique can be used successfully to study terminal innervation
of human muscle. In these investigations, however, it has been neces¬
sary to compare the results obtained for FTIR with the normal range for
human innervation obtained by the vital staining method (Coers, Telerman-
Toppet & Gerard 1973)» If the Ache/silver technique were to be used
regularly it would be essential to establish a normal range using this
method of staining.
An attempt at innervation studies in two volunteer heterozygous
carriers of the gene for Werdnig-Hoffmann disease was undertaken as
part of a study of the effect of the heterozygote gene on muscle and
peripheral nerve structure. There is some suggestive evidence from
electrophysiology that in female heterozygotes some manifestations can
be found in certain muscles (Emery, Anderson & Noronha 1973? Mawatari
& Katayama 1973)* The study of muscle histology and histochemistry of
the specimen from the two volunteers has not revealed any striking
difference between these and specimens of control muscle, although
there is an indication of increased variance in the size of Type II
fibres in the two heterozygotes (Lumb 1975» personal communication).
There are also a few abnormal axon terminals (Plate 1 ), but as was
mentioned earlier, these may be due to an ageing phenomenon (Harriman,
Taverner & Vt'oolf 1970).
In attempting any estimation of a normal range for functional
terminal innervation ratios it is essential to realise how many condi¬
tions result in atrophy of muscle, not to mention the loss of motor
units due to ageing (Campbell, McComas & Petito 1973)* In this pre¬
liminary study the only two specimens of muscle obtained at autopsy
from patients under fifty years of age would both have been discarded
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from a study of normal terminal innervation because of a pronounced
Type II fibre atrophy. One such patient was found to have suffered
from psychosis and it has been suggested that psychosis also has a pro¬
nounced effect on motor innervation (Meltzer & Crayton 1974).
The study of terminal innervation from certain diabetic patients
who have developed muscle weakness was intended as part of a larger
study of myopathic and neurogenic changes in this disease. Although
several biopsy specimens were received only the two reported here
were taken from the area of the motor point. It is impossible to dis¬
cuss terminal innervation in diabetic amyotrophy on the basis of these
two specimens. There is evidence to suggest that muscle weakness in
diabetes is a result of a neuropathy (Christenson 1972; Brown & Feasby
1974) and it would appear from these observations that in terms of peri¬
pheral innervation the resultant collateral ramification is easily dis¬
tinguishable from that found in lower motor neurone disease.
This study of innervation in human muscle has not been comprehensive.
It has, however, demonstrated clearly that the acetylcholinesterase/
silver technique can be used for terminal innervation studies in human
as well as animal muscle. One can use both fresh and post-mortem
material and it has the further advantage of not being time-consuming.
A specimen obtained in the morning can be analysed by the following
morning. The method is therefore most useful in those laboratories
where only the occasional terminal innervation study is a diagnostic
procedure for neuromuscular diseases.
%
PLATE 1
a) and b) Innervation in the deltoid muscle from a patient
with spinal muscular atrophy. Patient 1.
Ache/Silver impregnation x 525




a) Innervation in the deltoid muscle in a male carrier of
Werdniy-Hoffraarn type spinal muscular atrophy. Patient 2.
Ache/Silver impregnation x 400
A possibly branching axon can be seen
b) Innervation in the deltoid muscle of Patient 2
Ache/Silver impregnation x 400
Axonal swelling and an unusual end-plate structure can be seen
O
c) Innervation in the deltoid muscle in a female carrier of
Werdnig-Hoffraaivitype spinal muscular atrophy. Patient 3.
Ache/Silver impregnation x 400
A 'T • end-plate can be seen
d) Innervation in the deltoid muscle in Patient 3
Ache/Silver impregnation x 400
? A Duplex end-plate or possibly a branched axon.
P LATE 2
PLATE 3
a) and b) Innervation in the quadriceps muscle from a patient
with diabetic amyotrophy. Patient 4
Ache/Silver impregnation x 525
Terminal branching can be seen
c) A longitudinal section of quadriceps muscle showing
the end-plates on muscle. Patient 7
Ache-intensified with Silver/Light green counter stain x 160
The normal appear and distribution of end-plates can be seen
d) Section of quadriceps muscle showing areas of
cholinesterase activity in Patient 5 with diabetic
amyotrophy






a) Innervation in quadriceps muscle from Patient 6
Ache/Silver impregnation x 625
A duplex end-plate can be seen
b) Innervation in quadriceps muscle from Patient 6
Ache/Silver impregnation x 400
A branching axon can be seen
c) Innervation in quadriceps muscle from Patient 7
Ache/Silver impregnation x 400






The present study has considered several aspects of spinal muscu¬
lar atrophy in mice. The investigations have been carried out pri¬
marily on mice of the wobbler colony, although in parts of the study
mice from the dystrophic colony (ReJ/l29dy), have also been used.
The disease occurring in 'wobbler' mice is a hereditary neurological
condition resulting in anterior horn cell loss and muscular atrophy
(Duchen, Strich & Falconer 1968). The loss of motor neurones from
wobbler mouse spinal cord does not occur uniformly at all levels of
the cord. At early stages in the disease process, the degeneration
of anterior horn cells is principally in the cervical region, resulting
in the degeneration of fore limbs and pectoral musculature. Although
motor neurones may also be lost from the lumbar and lumbo-sacral
regions of the cord, it is uncommon for paralysis to occur in the hind
limbs of affected mice. At present it is not possible to give any
suggestions as to the biochemical lesions which might result in this
form of selective anterior horn cell loss. In this study, however,
free amino-acids have been estimated in cervical and lumbar regions
of the cord of both wobbler and dystrophic mutants. There is substan¬
tial evidence that a number of naturally occurring amino-acids function
as neural transmitters in the spinal cord (Curtis & Watkins i960,
Curtis 197^)* It has also been demonstrated that a loss of inter-
neurones from the spinal cord results in the loss of concentration of
the amino-acids glycine, aspartic acid and glutamic acid, all of which
are believed to function as neural transmitters (Davidoff et al).
Numerous forms of stress such as malnutrition and excessive tempera¬
tures have been shown to result in changes of free amino-acid concen¬
trations in the brain (Mcllwain & Bachalard 1971)• It was therefore
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considered that a phenomenon of motor neurone degeneration may also
affect the amino-acid profiles particularly in those areas of nervous
tissue predominantly affected by the disease process.
The results which have been discussed in detail in Chapter 4 indi¬
cate that the neuromuscular diseases occurring in both wobbler and
dystrophic mice do give rise to changes in amino-acid concentrations,
particularly in the cervical region of the spinal cord. The amino-
acids which are found in significantly lower concentrations in diseased
animals than in control (C57/BL) mice are three transmitter suspects;
aspartic acid, glutamic acid and glycine. It must be stressed, however,
that these amino-acids occur in the spinal cord in considerably higher
concentrations than most other amino-acids. It is therefore possible
that differences in these amino-acids are more easily detected. Never¬
theless, the results do indicate that free amino-acids in the nervous
system may be important in neuromuscular disease.
The results of amino-acid studies in the wobbler mouse further
suggest a possible involvement of a neurological transmitter substance
in the disease process. There are a number of pharmacological sub¬
stances believed to function as transmitters in the central nervous
system (Phyllis 197l)» The inter-relationship between the various
transmitters and their specificity for the neurone receptor-sites is
not fully understood. However, a number of pharmacologically active
substances such as J-amino-butyric acid and homocarnosine have been used
in the treatment of neurological conditions (Tallanl962, Hayashi 1965,
1966). It is interesting to find that it is the level of homocarnosine
that is raised in cervical and lumbar regions of wobbler mouse cord.
The manner in which homocarnosine functions is not known, but this
dipeptide appears to be specific to the central nervous system
(Abraham, Pisano & Underfriend 1961, 1962), and it is synthesised from
GABA and L-histidine, both these amino-acids have been shown to give
rise to neuronal excitability when topically applied. Furthermore,
homocarnosine has been suggested as a strong inhibitor in the limbic
motor system (Hayashi 1965» 1966). It may be unwise to speculate on
the manner in which homocarnosine functions in the nervous system and
whether increased levels of this dipeptide could lead to degeneration of
motor neurones. It is possible, however, that there is a direct link
between these two phenomena, particularly as the level of homocarnosine
is more significantly raised in the cervical region of the cord of
wobbler mice. Before any suggestions can be put forward as to how
horaocarnosine may affect anterior horn cells, its true role in the
nervous system must be clarified.
Throughout the study the wobbler mouse has been considered as a
possible analogue of human spinal muscular atrophy and suggestions
have been made that certain aspects, such as the amino-acids be followed
up using human material. If, however, the study is considered as a
whole, the problems which result from using animals as models for
human diseases can be seen very clearly. The use of the dystrophic
mouse as an analogue for Duchenne dystrophy has been questioned for
some time. There is increasing evidence that the neurological changes
found in the dystrophic mouse (Bradley & Jenkinson 1974, Biscoe 1974,
Bradley 1975) do not occur in the human disease (Emery & Gosdon 1974,
Bradley 1974). A large survey of peripheral innervation in Duchenne
dystrophy was carried out in 1965 (Jedrzejowski, Johnson & Voolf 1965)
and no abnormality in terminal innervation was noted. If a similar
study had been carried out on the dystrophic mouse, the abnormalities
reported in Chapter 5 of this study may have been noticed. In murine
dystrophy although peripheral branching is not the primary abnormality
of innervation it is, however, a significant feature in the hind-limb
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musculature. Therefore, although muscle histology in both the murine
and human diseases does show remarkable similarity, the innervation
studies are indicative of a variable disease process.
A considerable part of this study has been devoted to describing
the Wr/HLP mouse which arose spontaneously in the wobbler colony.
Genetic evidence reported in Chapter 3 suggests that the disease may
be associated with the heterozygous 'wr' gene. The results of muscle
and spinal cord histology given in Chapters 5, 6 and 7 suggest that
paralysis in the Wr/HLP mice may be the result of a lower motor neurone
disorder, which may possibly arise as an unusual manifestation of the
heterozygous wobbler gene. This hypothesis gains support from a
report by Harris (1975) of the occurrence of hind limb paralysis in
several wobbler mice, which he attributes to an unusual distribution
of muscle weakness in these animals rather than to a different disease
process. The existence of such variability in a single disease does,
however, raise the question of whether murine spinal muscular atrophy
is the result of a single gene abnormality. The possibility of a
different form of pathogenesis has been raised previously from the
result of earlier genetic findings in wobbler mice (Andrews et al 1974).
There is therefore substantial evidence to imply that the disease in
animals of the wobbler colony is vastly more complex than was origi¬
nally believed and hence, it would appear unwise to draw too many
analogies between the murine and human forms of spinal muscular
atrophy. There is increasing evidence to suggest that as work con¬
tinues on the wobbler mouse a similar situation will arise as is al¬
ready seen with the dystrophic mouse mutant, and numerous differences
will be found between the human and mouse forms of the disease. There
are those who already feel that the lower motor neurone disease result¬
ing from C-RNA lymphoma virus infection is a better model for the study
of human lower motor neurone diseases (Munsat 1975» Personal Communica¬
tion). The apparently variable manifestations of the disease process
in the genetically inherited anterior horn cell disease seen in the
wobbler colony may further substantiate this argument. The studies
of both wobbler and dystrophic mice indicate that caution must be taken
in discussing animal diseases in relation to known human disorders.
Animal models can, however, be useful in the furthering of knowledge
of a number of human conditions. Chapter 8 indicates how the tech¬
nique developed for assessing terminal innervation in mice was modified
for use on human material. This technique could prove valuable as it
enables the study of innervation in autopsy material. Further use of
the technique could give an indication of terminal innervation changes
which result from ageing or conditions known to affect the nervous
system but which would not normally warrant the taking of a muscle
biopsy.
Animal models have to be used for biochemical investigations of
those tissues which cannot be readily obtained from humans. The study
of amino-acid levels in human brain or cerebro-spinal fluid cannot be
carried out unless there is evidence that such a test is likely to be
of value to the patient. It is therefore important that animals with
conditions similar to a form of human disease be extensively studied
in order to act as indicators for possible metabolic lesions. However,
it appears very unwise to approach the study of a mouse mutant consi¬
dering it as an analogue of a human disease,when the similarities are
purely morphological.
The evidence given in the study is that murine spinal muscular
atrophy is a much more complex disease than was originally thought.
Not only do there appear to be variable forms of the disease in the
one colony, but also there are changes in amino-acid profiles in the
spinal cord which cannot be easily explained* It would therefore
appear that until such a time that more is known about the disease
in the mice of the wobbler colony, any reference to it being an ana¬
logue of human spinal muscular atrophy should be approached with caution.
APPENDIX
APPENDIX TO CHAPTER 2
Substrate Solution for NaDH-diaphorase Staining
DPNH solution (2-3 mg/ml) 0.7 ml
Nitro B.T. (0.2%) 2.5 ml
Phosphate buffer 0.2 M (pH 7*2 - 7«4) 1.0 ml
Ringer solution 0.8 ml
Substrate Solution for Myosin-ATPase Staining
Tris buffer 1.0 M 4 ml
Calcium chloride 6.Ho0 0.18 M
ATP (disodium salt) 30 mg
2 ml
Distilled water 14 ml
Final solution adjusted to pH 9»5 with 0.1 N HCL
The Method for Localisation of Cholinesterase Activity
a) Muscle
- Fix 20 jx sections in formal calcium 1 hr
- Wash in distilled water
- Incubate at room temperature in cholinesterase solution
5 min
- Wash well in distilled water
- Place £ min in 1% AgNO^
- Wash well in distilled water
- Place £ min in 10% thio
- Wash well
- Counter stain with 1% light green
- D.C.M.
b) Spinal Cord
As above but leave for 1 hr in cholinesterase solution
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4. Technique for combined staining of cholinesterase and nerve fibres
a) Mouse Muscle
- Cut longitudinal sections 40-50 jjl thick
- Rapidly dry on to slide with cold air from hair drier
- Fix in cold Formal calcium 2 hrs
- Wash in distilled HO
2
- Incubate at room temperature in cholinesterase solution
1$ rain
- Wash several times in distilled H^O
- Leave 1 hr in distilled HO in fridge
4b
- 0.25% Potassium Ferricyanide 8-10 rain
- Wash several times in distilled HO
- Leave 1 hr in absolute alcohol
- Rehydrate 1 rain in distilled HO
4m*
- Silver solution at 37°C - 45 min to 1 hr
- Wash in distilled HO - 2-5 rain. Use a test slide: place
into developer an3 see how quickly it darkens - if too
rapidly leave sections longer in water
- Place into reducing solution - one slide at a time agitating
the slide in the solution for the first min. Place into
second jar of solution, leave until the section darkens to
a lightish brown or lightish green




- Cut longitudinal sections 10O thick
- Fix free-floating in formal calcium at 4°C 2 hrs
- Remove sections from formal calcium to water
- Mount on to slides and allow to dry
- Incubate at room temperature in cholinesterase solution 2-2^ min
Continue as for mouse but reduce the time in 0.25% Potassium
Ferricyani'de to 4-5 min




10 gms Ca. Acetate
100 ml Formalin
900 ml Distilled water
Cholinesterase Solution
100 mg Acetyl - thiocholine iodide
+ 4 ml Distilled HO
+ 7 ml M/io Cuso. 5Ho0 - very slowlyH 2
(6.25 gms in 100 ml)
leave 10 min - filter
+ 62 mg glycine
+ J ml M/l Sodium acetate (136 g litre) - pH about 5*1
made up to 50 with distilled water
Silver Solution
10 gms AgN03
0.05 g CuS04 5H2O
0.10 g CaCo^
lOO ml Distilled HO
Reducing Solution
0.5 g Hydroquinone
10 g Na SO 7H 02 3 2
lOO ml Distilled HO
2
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APPENDIX TO CHAPTER 4
TABLE 1
A List of the Amino-Acids that are estimated
on the Amino-Acid Analyses
An indication is given whether the amino-acids are found in spinal
cord samples.
Amino-acid Amino-acid
Cysteic acid * * Isoleucine •
P-ethanolamine * ♦ ♦ Leucine •
Hydroxypholine 0 Phenylalanine *
Aspartic acid *** Ethanolamine *
Threonine * • BIAB 0
Serine »• Ornithine ♦ *
Glutamine • * • Lysine ♦ *
Asparagine 0 Histidine * *
Glutamic acid »»» Tryptophan 0
Alanine ** ♦ * * Homocarnosine/
* *





•• = Concentrations < 1.0 yx moles/gm ) Regults f<>r theae ^
... ~ ^ \ given in Chapter 4•** = Concentrations y i.O yx moles/gm )
Results for 14 amino-acids given in Chapter 4.
APPENDIX TO CHAPTER 4
TABLE 2
Amino-Acid Concentrations in Cervical
and Lumbar Cord of the Wobbler
and the Dystrophic Littermates
Results given as yn moles/gm wet wht (M- SD)
Cervical cord Lumbar cord































































































































APPENDIX TO CHAPTER 5
TABLE 1
RESULTS OF FTIR STUDIES IN MICE


























































































































Age in days 146 173 303 90 4?
dydy Tot.no.of axons 56 48 40 46 42
FTIR 1.13 1.13 1.10 1.11 1.14
APPENDIX TO CHAPTER 5
TABLE 2
SIZES OF END-PLATES (p)
100 end-plates in each individual mouse
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